Drug Description in Trials / DrugBank / KEGG DRUG


Search results


No. 薬物名(臨床試験情報から抽出) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
1C-028380----1件: 106 💬
2C-1-esterase----1件: 65 💬
3C-11 ER176----3件: 6, 17, 127 💬
4C-11 ER176 radiotracer----1件: 13 💬
5C-11 PIB1件: Pittsburgh Compound B---3件: 6, 17, 127 💬
6C-KIT+ cells----1件: 211 💬
7C-type natriuretic peptide conjugated TO A multi-ARM polyethylene glycol carrier molecule through A cleavable linker----1件: 276 💬
8C-type natriuretic peptide conjugated TO multi-ARM polyethylene glycol carrier through A cleavable linker----1件: 276 💬
9C. albicans----1件: 46 💬
10C01ca04 - dopamina----1件: 299 💬
11C01eb19----1件: 65 💬
12C03xa01----2件: 67, 72 💬
13C07ab07----1件: 86 💬
14C09----1件: 66 💬
15C1 esterase inhibitor----1件: 65 💬
16C1 esterase inhibitor [human] liquid----1件: 65 💬
17C1 esterase inhibitor concentrate----1件: 65 💬
18C1 esterase inhibitor concentrate, human, pasteurized----1件: 65 💬
19C1 esterase inhibitor human----1件: 65 💬
20C1 esterase inhibitor liquid FOR injection----1件: 65 💬
21C1 inhibitor1件: Human C1-esterase inhibitor---1件: 65 💬
22C1 inhibitor concentrate1件: Human C1-esterase inhibitor---1件: 65 💬
23C1-esterase inhibitor----1件: 65 💬
24C1-esterase inhibitor - single intravenous dose----1件: 65 💬
25C1-esterase inhibitor - subcutaneous high dose----1件: 65 💬
26C1-esterase inhibitor - subcutaneous LOW dose----1件: 65 💬
27C1-esterase inhibitor - subcutaneous medium dose----1件: 65 💬
28C1-esterase-inhibitor----1件: 65 💬
29C1-INH1件: Human C1-esterase inhibitor---1件: 65 💬
30C105----1件: 13 💬
31C106 solution----1件: 85 💬
32C10aa05----1件: 46 💬
33C10ab02----1件: 94 💬
34C11 pittsburgh compound B----1件: 13 💬
35C11-methionine----1件: 84 💬
36C11-SY08----2件: 6, 17 💬
37C21----2件: 51, 85 💬
38C225----2件: 51, 86 💬
39C2L-OCT-01 PR----1件: 77 💬
40C2L-OCT-01 PR , 10MG----1件: 77 💬
41C2L-OCT-01 PR , 20MG----1件: 77 💬
42C2L-OCT-01 PR , 30MG----1件: 77 💬
43C2L-OCT-01 PR 30 MG----1件: 77 💬
44C2L-OCT-01 PR, 10 or 20 MG----1件: 77 💬
45C2L-OCT-01 PR, 20 MG----1件: 77 💬
46C2L-OCT-01 PR, 30 MG----1件: 77 💬
47C326, IL-6 inhibitory avimer protein1件: C326---1件: 96 💬
48C5 INH MAB, SKY59, RO/CH7092230----2件: 62, 109 💬
49C5 inhibitor----1件: 62 💬
50CA2----1件: 271 💬
51CABA-201----3件: 11, 49, 51 💬
52CABA-201 following preconditioning with fludarabine and cyclophosphamide----1件: 50 💬
53Cabaletta1件: Trehalose---1件: 113 💬
54Cabaletta FOR IV infusion once weekly during 24 weeks1件: Trehalose---1件: 18 💬
55Cabaser----2件: 6, 77 💬
56Cabaseril----1件: 6 💬
57Cabaseril, 1,0 MG tablette----1件: 6 💬
58Cabaseril, 2,0 MG tablette----1件: 6 💬
59Cabergolin----1件: 77 💬
60Cabergolina1件: Cabergoline1件: Cabergoline 💬 2件: DRD2,
PRL 💬
14件: Alcoholism, Cocaine addiction, Cytokine-cytokine receptor interaction, Dopaminergic synapse, Gap junction, Hormone signaling, JAK-STAT signaling pathway, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Parkinson disease, Prolactin signaling pathway, Rap1 signaling pathway, cAMP signaling pathway 💬2件: 6, 75 💬
61Cabergoline1件: Cabergoline1件: Cabergoline 💬 2件: DRD2,
PRL 💬
14件: Alcoholism, Cocaine addiction, Cytokine-cytokine receptor interaction, Dopaminergic synapse, Gap junction, Hormone signaling, JAK-STAT signaling pathway, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Parkinson disease, Prolactin signaling pathway, Rap1 signaling pathway, cAMP signaling pathway 💬4件: 6, 74, 75, 77 💬
62Cabergoline teva1件: Cabergoline1件: Cabergoline 💬 2件: DRD2,
PRL 💬
14件: Alcoholism, Cocaine addiction, Cytokine-cytokine receptor interaction, Dopaminergic synapse, Gap junction, Hormone signaling, JAK-STAT signaling pathway, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Parkinson disease, Prolactin signaling pathway, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 75 💬
63Cablivi1件: Caplacizumab1件: Caplacizumab 💬 1件: VWF 💬 8件: Complement and coagulation cascades, Coronavirus disease - COVID-19, ECM-receptor interaction, Focal adhesion, Human papillomavirus infection, Neutrophil extracellular trap formation, PI3K-Akt signaling pathway, Platelet activation 💬1件: 64 💬
64Cablivi®----1件: 64 💬
65Cabozantinib1件: Cabozantinib2件: Cabozantinib ,
Cabozantinib s-malate 💬
3件: AXL,
KDR,
MET 💬
25件: Adherens junction, Axon guidance, Bacterial invasion of epithelial cells, Calcium signaling pathway, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Efferocytosis, Epithelial cell signaling in Helicobacter pylori infection, Fluid shear stress and atherosclerosis, Focal adhesion, Gastric cancer, Hepatocellular carcinoma, MAPK signaling pathway, Malaria, Melanoma, MicroRNAs in cancer, Non-small cell lung cancer, PI3K-Akt signaling pathway, Pathways in cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Renal cell carcinoma, Transcriptional misregulation in cancer, VEGF signaling pathway 💬1件: 34 💬
66Cabozantinib oral tablet1件: Cabozantinib2件: Cabozantinib ,
Cabozantinib s-malate 💬
3件: AXL,
KDR,
MET 💬
25件: Adherens junction, Axon guidance, Bacterial invasion of epithelial cells, Calcium signaling pathway, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Efferocytosis, Epithelial cell signaling in Helicobacter pylori infection, Fluid shear stress and atherosclerosis, Focal adhesion, Gastric cancer, Hepatocellular carcinoma, MAPK signaling pathway, Malaria, Melanoma, MicroRNAs in cancer, Non-small cell lung cancer, PI3K-Akt signaling pathway, Pathways in cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Renal cell carcinoma, Transcriptional misregulation in cancer, VEGF signaling pathway 💬1件: 34 💬
67Cacipliq20----1件: 36 💬
68Cacit D3 effervescent granules, 500 MG/440 IU----1件: 97 💬
69CADD-legacy ambulatory infusion pump----1件: 6 💬
70CADD-legacy® 1400 ambulatory infusion pump----1件: 6 💬
71CAEL-101----1件: 28 💬
72Caffeic acid tablets----1件: 63 💬
73Caffeine1件: Caffeine3件: Caffeine ,
Caffeine hydrate ,
Caffeine citrate 💬
11件: ADORA1,
ADORA2A,
PDE1,
PDE2A,
PDE3A,
PDE3B,
PDE4,
PDE4,
PDE4,
PDE4,
PDE5 💬
22件: Alcoholism, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Glucagon signaling pathway, Insulin signaling pathway, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Olfactory transduction, Parathyroid hormone synthesis, secretion and action, Parkinson disease, Progesterone-mediated oocyte maturation, Purine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Taste transduction, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬8件: 2, 6, 13, 21, 46, 96, 97, 265 💬
74Caffeine 100 MG1件: Caffeine3件: Caffeine ,
Caffeine hydrate ,
Caffeine citrate 💬
11件: ADORA1,
ADORA2A,
PDE1,
PDE2A,
PDE3A,
PDE3B,
PDE4,
PDE4,
PDE4,
PDE4,
PDE5 💬
22件: Alcoholism, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Glucagon signaling pathway, Insulin signaling pathway, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Olfactory transduction, Parathyroid hormone synthesis, secretion and action, Parkinson disease, Progesterone-mediated oocyte maturation, Purine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Taste transduction, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬2件: 96, 97 💬
75Caffeine 100-200 MG BID1件: Caffeine3件: Caffeine ,
Caffeine hydrate ,
Caffeine citrate 💬
11件: ADORA1,
ADORA2A,
PDE1,
PDE2A,
PDE3A,
PDE3B,
PDE4,
PDE4,
PDE4,
PDE4,
PDE5 💬
22件: Alcoholism, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Glucagon signaling pathway, Insulin signaling pathway, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Olfactory transduction, Parathyroid hormone synthesis, secretion and action, Parkinson disease, Progesterone-mediated oocyte maturation, Purine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Taste transduction, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 6 💬
76Caffeine alkaloid1件: Caffeine3件: Caffeine ,
Caffeine hydrate ,
Caffeine citrate 💬
11件: ADORA1,
ADORA2A,
PDE1,
PDE2A,
PDE3A,
PDE3B,
PDE4,
PDE4,
PDE4,
PDE4,
PDE5 💬
22件: Alcoholism, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Glucagon signaling pathway, Insulin signaling pathway, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Olfactory transduction, Parathyroid hormone synthesis, secretion and action, Parkinson disease, Progesterone-mediated oocyte maturation, Purine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Taste transduction, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 6 💬
77CAL101----1件: 85 💬
78Calcichew D3----1件: 274 💬
79Calcichew D3 forte----1件: 113 💬
80Calcichew tablets----1件: 274 💬
81Calcifediol1件: Calcifediol1件: Calcifediol 💬 1件: VDR 💬 5件: Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬1件: 113 💬
82Calcifediol oral capsule1件: Calcifediol1件: Calcifediol 💬 1件: VDR 💬 5件: Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬1件: 86 💬
83Calciferol1件: Vitamin D---1件: 49 💬
84Calcineurin inhibitors----1件: 50 💬
85Calcineurin inhibitors maintenance----1件: 67 💬
86Calcio1件: Calcium---3件: 13, 96, 97 💬
87Calcio carbonato/colecalciferolo2件: Calcium,
Calcium carbonate
2件: Calcium carbonate ,
Calcium carbonate 💬
--1件: 274 💬
88Calcipotriene1件: Calcipotriol2件: Calcipotriene ,
Calcipotriol hydrate 💬
1件: VDR 💬 5件: Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬1件: 51 💬
89Calcipotriol1件: Calcipotriol2件: Calcipotriene ,
Calcipotriol hydrate 💬
1件: VDR 💬 5件: Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬1件: 36 💬
90Calcitonin----1件: 225 💬
91Calcitriol1件: Calcitriol1件: Calcitriol 💬 1件: VDR 💬 5件: Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬8件: 18, 37, 46, 49, 66, 96, 235, 326 💬
92Calcitriol & calcium1件: Calcitriol1件: Calcitriol 💬 1件: VDR 💬 5件: Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬1件: 235 💬
93Calcium2件: Calcium,
Calcium carbonate
2件: Calcium carbonate ,
Calcium carbonate 💬
--12件: 6, 46, 49, 68, 93, 95, 97, 156, 222, 235, 271, 274 💬
94Calcium and cholecalciferol2件: Calcium,
Cholecalciferol
1件: Cholecalciferol 💬 1件: VDR 💬 5件: Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬1件: 46 💬
95Calcium and VIT D1件: Calcium---1件: 49 💬
96Calcium and vitamin D combination1件: Calcium---1件: 13 💬
97Calcium carbonate2件: Calcium,
Calcium carbonate
2件: Calcium carbonate ,
Calcium carbonate 💬
--7件: 13, 19, 46, 75, 96, 235, 299 💬
98Calcium carbonate 600 MG once daily2件: Calcium,
Calcium carbonate
2件: Calcium carbonate ,
Calcium carbonate 💬
--1件: 97 💬
99Calcium carbonate and alphacalcidol2件: Calcium,
Calcium carbonate
2件: Calcium carbonate ,
Calcium carbonate 💬
--1件: 235 💬
100Calcium carbonate D2件: Calcium,
Calcium carbonate
2件: Calcium carbonate ,
Calcium carbonate 💬
--1件: 53 💬
101Calcium carbonate tablets2件: Calcium,
Calcium carbonate
2件: Calcium carbonate ,
Calcium carbonate 💬
--1件: 46 💬
102Calcium channel blockers1件: Calcium---1件: 51 💬
103Calcium citrate3件: Calcium,
Calcium carbonate,
Calcium citrate
3件: Calcium carbonate ,
Calcium citrate ,
Calcium carbonate 💬
--2件: 46, 235 💬
104Calcium citrate with vitamin D23件: Calcium,
Calcium citrate,
Ergocalciferol
2件: Ergocalciferol ,
Calcium citrate 💬
1件: VDR 💬 5件: Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬1件: 84 💬
105Calcium D3 sandoz - 1000 MG + 880 U.I. compresse effervescenti 30 compresse divisibili2件: Calcium,
Calcium carbonate
2件: Calcium carbonate ,
Calcium carbonate 💬
--1件: 274 💬
106Calcium gluconate2件: Calcium,
Calcium gluconate
1件: Calcium gluconate 💬 --3件: 214, 215, 235 💬
107Calcium lactate2件: Calcium,
Calcium lactate
2件: Calcium lactate ,
Calcium lactate hydrate 💬
--1件: 235 💬
108Calcium levofolinate1件: Calcium---1件: 13 💬
109Calcium stable isotope1件: Calcium---1件: 186 💬
110Calcium, dietary1件: Calcium---1件: 298 💬
111Calculus bovis1件: Bos taurus gallstone---1件: 13 💬
112Calfactant1件: Calfactant1件: Calfactant 💬 --1件: 299 💬
113Calogen----1件: 2 💬
114Calprotectin----1件: 97 💬
115Caltrate----1件: 97 💬
116Caltrate pill----1件: 96 💬
117Calvan tablets 100----1件: 8 💬
118Calvan® 100 MG----1件: 8 💬
119CALY-0021件: CALY-002---1件: 98 💬
120CAM-30011件: Mavrilimumab1件: Mavrilimumab 💬 1件: CSF2RA 💬 4件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer 💬1件: 46 💬
121CAM2029----1件: 77 💬
122CAM2029 (octreotide subcutaneous depot) _prefilled syringe_prefilled syringe1件: Octreotide4件: Octreotide ,
Octreotide acetate ,
Octreotide pamoate ,
Octreotide acetate 💬
1件: SSTR2 💬 5件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 77 💬
123CAM2029 (octreotide subcutaneous depot)_ prefilled PEN1件: Octreotide4件: Octreotide ,
Octreotide acetate ,
Octreotide pamoate ,
Octreotide acetate 💬
1件: SSTR2 💬 5件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 77 💬
124CAM2029 (octreotide subcutaneous depot)_ prefilled syringe1件: Octreotide4件: Octreotide ,
Octreotide acetate ,
Octreotide pamoate ,
Octreotide acetate 💬
1件: SSTR2 💬 5件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 77 💬
125CAM2029 (octreotide subcutaneous depot)_pre-filled PEN1件: Octreotide4件: Octreotide ,
Octreotide acetate ,
Octreotide pamoate ,
Octreotide acetate 💬
1件: SSTR2 💬 5件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 77 💬
126CAM2029 (octreotide subcutaneous depot)_pre-filled syringe1件: Octreotide4件: Octreotide ,
Octreotide acetate ,
Octreotide pamoate ,
Octreotide acetate 💬
1件: SSTR2 💬 5件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 77 💬
127CAM2029 (octreotide subcutaneous depot)_prefilled PEN1件: Octreotide4件: Octreotide ,
Octreotide acetate ,
Octreotide pamoate ,
Octreotide acetate 💬
1件: SSTR2 💬 5件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 77 💬
128CAM2029 (octreotide subcutaneous depot)_prefilled syringe1件: Octreotide4件: Octreotide ,
Octreotide acetate ,
Octreotide pamoate ,
Octreotide acetate 💬
1件: SSTR2 💬 5件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 77 💬
129CAM2029-BR----1件: 77 💬
130CAM2043----1件: 51 💬
131Camoteskimab1件: Camoteskimab---1件: 54 💬
132Campath1件: Alemtuzumab1件: Alemtuzumab 💬 --3件: 49, 51, 60 💬
133Campath -1H----1件: 65 💬
134Campath 1H----4件: 60, 65, 164, 285 💬
135Campath, busulfan, clofarabine----1件: 326 💬
136Campath, chemo and/or TBI allo SCT----3件: 60, 62, 283 💬
137Campath, fludarabine, cyclophosphamide----2件: 65, 284 💬
138Campath-1H1件: Alemtuzumab1件: Alemtuzumab 💬 --6件: 19, 20, 60, 65, 234, 326 💬
139Canakinumab1件: Canakinumab1件: Canakinumab 💬 1件: IL1B 💬 43件: AGE-RAGE signaling pathway in diabetic complications, African trypanosomiasis, Alcoholic liver disease, Alzheimer disease, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human cytomegalovirus infection, IL-17 signaling pathway, Inflammatory bowel disease, Inflammatory mediator regulation of TRP channels, Influenza A, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Rheumatoid arthritis, Salmonella infection, Shigellosis, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Tuberculosis, Type I diabetes mellitus, Yersinia infection 💬11件: 46, 54, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬
140Canakinumab - proposed1件: Canakinumab1件: Canakinumab 💬 1件: IL1B 💬 43件: AGE-RAGE signaling pathway in diabetic complications, African trypanosomiasis, Alcoholic liver disease, Alzheimer disease, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human cytomegalovirus infection, IL-17 signaling pathway, Inflammatory bowel disease, Inflammatory mediator regulation of TRP channels, Influenza A, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Rheumatoid arthritis, Salmonella infection, Shigellosis, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Tuberculosis, Type I diabetes mellitus, Yersinia infection 💬1件: 106 💬
141Canakinumab injection1件: Canakinumab1件: Canakinumab 💬 1件: IL1B 💬 43件: AGE-RAGE signaling pathway in diabetic complications, African trypanosomiasis, Alcoholic liver disease, Alzheimer disease, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human cytomegalovirus infection, IL-17 signaling pathway, Inflammatory bowel disease, Inflammatory mediator regulation of TRP channels, Influenza A, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Rheumatoid arthritis, Salmonella infection, Shigellosis, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Tuberculosis, Type I diabetes mellitus, Yersinia infection 💬1件: 46 💬
142Candesartan1件: Candesartan1件: Candesartan 💬 1件: AGTR1 💬 17件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hormone signaling, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬2件: 58, 67 💬
143Candesartan and cilnidipine1件: Candesartan1件: Candesartan 💬 1件: AGTR1 💬 17件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hormone signaling, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 67 💬
144Candesartan plus NON-CCB agents1件: Candesartan1件: Candesartan 💬 1件: AGTR1 💬 17件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hormone signaling, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 67 💬
145Candy glucose tolerance test----1件: 299 💬
146Cannabidiol1件: Cannabidiol1件: Cannabidiol 💬 2件: CNR1,
CNR2 💬
4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬18件: 6, 8, 13, 19, 36, 46, 95, 96, 97, 140, 144, 145, 156, 157, 158, 193, 206, 271 💬
147Cannabidiol , synthetic form1件: Cannabidiol1件: Cannabidiol 💬 2件: CNR1,
CNR2 💬
4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬1件: 96 💬
148Cannabidiol / dronabinol capsule 5 MG+2,5 MG2件: Cannabidiol,
Dronabinol
2件: Dronabinol ,
Cannabidiol 💬
2件: CNR1,
CNR2 💬
4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬1件: 13 💬
149Cannabidiol 100 MG/ML1件: Cannabidiol1件: Cannabidiol 💬 2件: CNR1,
CNR2 💬
4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬1件: 6 💬
150Cannabidiol 300 MG/ML1件: Cannabidiol1件: Cannabidiol 💬 2件: CNR1,
CNR2 💬
4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬1件: 6 💬
151Cannabidiol 400 MG/ML1件: Cannabidiol1件: Cannabidiol 💬 2件: CNR1,
CNR2 💬
4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬1件: 6 💬
152Cannabidiol capsule 5 MG1件: Cannabidiol1件: Cannabidiol 💬 2件: CNR1,
CNR2 💬
4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬1件: 13 💬
153Cannabidiol oral solution1件: Cannabidiol1件: Cannabidiol 💬 2件: CNR1,
CNR2 💬
4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬4件: 140, 144, 145, 193 💬
154Cannabidiol tablet 10 MG1件: Cannabidiol1件: Cannabidiol 💬 2件: CNR1,
CNR2 💬
4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬2件: 46, 271 💬
155Cannabidiol vaginal suppository1件: Cannabidiol1件: Cannabidiol 💬 2件: CNR1,
CNR2 💬
4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬1件: 226 💬
156Cannabidiolo----1件: 156 💬
157Cannabigerol1件: Cannabigerol---1件: 46 💬
158Cannabinol1件: Cannabinol---1件: 36 💬
159Cannabis1件: Medical Cannabis1件: Cannabis 💬 --3件: 13, 46, 90 💬
160Cannabis OIL1件: Medical Cannabis1件: Cannabis 💬 --1件: 6 💬
161Cannabis questionnaire1件: Medical Cannabis1件: Cannabis 💬 --2件: 46, 271 💬
162Cannabis sativa extract oromucosal spray1件: Medical Cannabis1件: Cannabis 💬 --1件: 2 💬
163Cannabis sativa L., folium CUM flore1件: Medical Cannabis1件: Cannabis 💬 --1件: 19 💬
164Cannabis, medical1件: Medical Cannabis1件: Cannabis 💬 --5件: 2, 6, 13, 96, 97 💬
165Cannador----1件: 13 💬
166CAP-1002----1件: 113 💬
167Capacity OF muscular oxygen extraction----1件: 13 💬
168Capecitabine1件: Capecitabine1件: Capecitabine 💬 1件: thyA 💬 3件: Folate transport and metabolism, One carbon pool by folate, Pyrimidine metabolism 💬1件: 94 💬
169Capillarema----1件: 51 💬
170Caplacizumab1件: Caplacizumab1件: Caplacizumab 💬 1件: VWF 💬 8件: Complement and coagulation cascades, Coronavirus disease - COVID-19, ECM-receptor interaction, Focal adhesion, Human papillomavirus infection, Neutrophil extracellular trap formation, PI3K-Akt signaling pathway, Platelet activation 💬2件: 63, 64 💬
171Caprylic triglyceride1件: Tricaprylin1件: Tricaprilin 💬 --1件: 13 💬
172Capsaicin1件: Capsaicin1件: Capsaicin 💬 1件: TRPV1 💬 2件: Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction 💬4件: 2, 6, 86, 226 💬
173Capsaicin challenge1件: Capsaicin1件: Capsaicin 💬 1件: TRPV1 💬 2件: Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction 💬1件: 2 💬
174Capsaicin vapor1件: Capsaicin1件: Capsaicin 💬 1件: TRPV1 💬 2件: Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction 💬1件: 6 💬
175Capsule DI prednisone1件: Prednisone1件: Prednisone 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 41 💬
176Capsule endoscopy----1件: 96 💬
177Captopril1件: Captopril1件: Captopril 💬 1件: ACE 💬 6件: Chagas disease, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system 💬2件: 17, 86 💬
178Capture1件: Bifenthrin---2件: 46, 149 💬
179CAR T cell----1件: 50 💬
180CAR-NK cell----1件: 53 💬
181CAR-T cell----1件: 49 💬
182CAR-T cells----1件: 63 💬
183CAR-T therapy----2件: 49, 51 💬
184Carbaglu1件: Carglumic acid1件: Carglumic acid 💬 1件: CPS1 💬 3件: Alanine, aspartate and glutamate metabolism, Arginine biosynthesis, Nitrogen metabolism 💬2件: 245, 246 💬
185Carbamazepine1件: Carbamazepine1件: Carbamazepine 💬 5件: SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A 💬
3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬3件: 6, 13, 231 💬
186Carbetocin1件: Carbetocin1件: Carbetocin 💬 1件: OXTR 💬 5件: Calcium signaling pathway, Hormone signaling, Neuroactive ligand-receptor interaction, Oxytocin signaling pathway, cAMP signaling pathway 💬1件: 193 💬
187Carbidopa1件: Carbidopa1件: Carbidopa 💬 1件: DDC 💬 8件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬5件: 6, 13, 17, 140, 201 💬
188Carbidopa 20 MG1件: Carbidopa1件: Carbidopa 💬 1件: DDC 💬 8件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬1件: 6 💬
189Carbidopa 200MG oral dose1件: Carbidopa1件: Carbidopa 💬 1件: DDC 💬 8件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬2件: 6, 17 💬
190Carbidopa 25/levodopa 100MG TAB1件: Carbidopa1件: Carbidopa 💬 1件: DDC 💬 8件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬1件: 6 💬
191Carbidopa 27.5 MG1件: Carbidopa1件: Carbidopa 💬 1件: DDC 💬 8件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬1件: 6 💬
192Carbidopa 65 MG capsule1件: Carbidopa1件: Carbidopa 💬 1件: DDC 💬 8件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬1件: 6 💬
193Carbidopa and levodopa controlled release tablets2件: Carbidopa,
Levodopa
2件: Levodopa ,
Carbidopa 💬
6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬
17件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
194Carbidopa and levodopa tablets, USP2件: Carbidopa,
Levodopa
2件: Levodopa ,
Carbidopa 💬
6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬
17件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
195Carbidopa anidra1件: Carbidopa1件: Carbidopa 💬 1件: DDC 💬 8件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬1件: 6 💬
196Carbidopa INN1件: Carbidopa1件: Carbidopa 💬 1件: DDC 💬 8件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬1件: 6 💬
197Carbidopa levodopa2件: Carbidopa,
Levodopa
2件: Levodopa ,
Carbidopa 💬
6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬
17件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
198Carbidopa monohydrate1件: Carbidopa1件: Carbidopa 💬 1件: DDC 💬 8件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬1件: 6 💬
199Carbidopa pill1件: Carbidopa1件: Carbidopa 💬 1件: DDC 💬 8件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬1件: 6 💬
200Carbidopa, levodopa, entacapone1件: Carbidopa1件: Carbidopa 💬 1件: DDC 💬 8件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬1件: 6 💬
201Carbidopa- levodopa1件: Carbidopa1件: Carbidopa 💬 1件: DDC 💬 8件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬1件: 6 💬
202Carbidopa-4'-monophosphate1件: Carbidopa1件: Carbidopa 💬 1件: DDC 💬 8件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬1件: 6 💬
203Carbidopa-levodopa2件: Carbidopa,
Levodopa
2件: Levodopa ,
Carbidopa 💬
6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬
17件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
204Carbidopa-levodopa 25 MG-100 MG oral tablet1件: Carbidopa1件: Carbidopa 💬 1件: DDC 💬 8件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬1件: 6 💬
205Carbidopa/L-dopa/entacapone3件: Carbidopa,
Entacapone,
Levodopa
3件: Levodopa ,
Carbidopa ,
Entacapone 💬
7件: COMT,
DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬
18件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Steroid hormone biosynthesis, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
206Carbidopa/levodopa2件: Carbidopa,
Levodopa
2件: Levodopa ,
Carbidopa 💬
6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬
17件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
207Carbidopa/levodopa, AS prescribed BY treating physician1件: Carbidopa1件: Carbidopa 💬 1件: DDC 💬 8件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬1件: 6 💬
208Carbidopa/levodopa, immediate release1件: Carbidopa1件: Carbidopa 💬 1件: DDC 💬 8件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬1件: 6 💬
209Carbidopa/levodopa/entacapone1件: Carbidopa1件: Carbidopa 💬 1件: DDC 💬 8件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬1件: 6 💬
210Carbidopamonohydraat----1件: 6 💬
211Carbodopa levadopa----1件: 6 💬
212Carbodopa/levadopa----1件: 6 💬
213Carbohydrates intake----1件: 257 💬
214Carbolithium----1件: 2 💬
215Carbolithium*100CPS 150MG----1件: 2 💬
216Carbomer1件: Carbomer---1件: 53 💬
217Carbomer 974P2件: Carbomer,
Carbopol 974P
---1件: 53 💬
218Carbomer GEL/jelly1件: Carbomer---1件: 53 💬
219Carbon1件: Activated charcoal1件: Charcoal, activated 💬 --4件: 6, 97, 149, 235 💬
220Carbon dioxide2件: Activated charcoal,
Carbon dioxide
2件: Carbon dioxide ,
Charcoal, activated 💬
--2件: 51, 158 💬
221Carbon dioxide insufflation2件: Activated charcoal,
Carbon dioxide
2件: Carbon dioxide ,
Charcoal, activated 💬
--1件: 97 💬
222Carbon dioxide insufflation during colonoscopy2件: Activated charcoal,
Carbon dioxide
2件: Carbon dioxide ,
Charcoal, activated 💬
--1件: 97 💬
223Carbon monoxide2件: Activated charcoal,
Carbon monoxide
2件: Charcoal, activated ,
Carbon monoxide 💬
--1件: 86 💬
224Carbon monoxide-bubbled mediums2件: Activated charcoal,
Carbon monoxide
2件: Charcoal, activated ,
Carbon monoxide 💬
--1件: 298 💬
225Carbon-14 BIA 28-61561件: Activated charcoal1件: Charcoal, activated 💬 --1件: 6 💬
226Carbon-14 labeled HSK392971件: Activated charcoal1件: Charcoal, activated 💬 --1件: 62 💬
227Carbonate DE lithium1件: Carbonate ion---1件: 2 💬
228Carbone vegetale polvere----1件: 13 💬
229Carboplatin1件: Carboplatin1件: Carboplatin 💬 --4件: 28, 34, 60, 85 💬
230Carbossimaltosio ferrico----1件: 97 💬
231Carboxy methyl cellulose----1件: 53 💬
232Carboxymethylcellulose1件: Carboxymethylcellulose2件: Carboxymethylcellulose sodium ,
Carmellose 💬
--2件: 35, 162 💬
233Cardiac evaluation----1件: 3 💬
234Cardiac monitoring----1件: 6 💬
235Cardiac MRI----3件: 113, 215, 216 💬
236Cardiac progenitor cell infusion----2件: 210, 211 💬
237Cardiomems pulmonary artery pressure monitor----1件: 86 💬
238Cardiopulmonary evaluation----1件: 13 💬
239Cardiopulmonary exercise testing----1件: 21 💬
240Cardiovascular profile----1件: 113 💬
241Cardura1件: Doxazosin2件: Doxazosin mesylate ,
Doxazosin 💬
3件: ADRA1A,
ADRA1B,
ADRA1D 💬
9件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 67 💬
242Care AS usual----1件: 15 💬
243Carfilzomib1件: Carfilzomib1件: Carfilzomib 💬 1件: PSMB5 💬 8件: Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 💬1件: 28 💬
244Carglumic acid1件: Carglumic acid1件: Carglumic acid 💬 1件: CPS1 💬 3件: Alanine, aspartate and glutamate metabolism, Arginine biosynthesis, Nitrogen metabolism 💬3件: 245, 246, 251 💬
245Carisbamate1件: Carisbamate1件: Carisbamate 💬 --1件: 144 💬
246Carisbamate (S)-2-O-carbamoyl-1-O-chlorophenyl-ethanol1件: Carisbamate1件: Carisbamate 💬 --1件: 144 💬
247Carmustina1件: Carmustine1件: Carmustine 💬 --1件: 13 💬
248Carmustine1件: Carmustine1件: Carmustine 💬 --5件: 11, 13, 14, 28, 60 💬
249Carnitine1件: Levocarnitine2件: Levocarnitine chloride ,
Levocarnitine 💬
--3件: 46, 58, 265 💬
250Carnosine supplementation1件: Carnosine---1件: 6 💬
251Carnosine, capsulle, 2 G/DAY, 8 weeks1件: Carnosine---1件: 13 💬
252Carotegrast methyl1件: Carotegrast methyl1件: Carotegrast methyl 💬 3件: ITGA4,
ITGB1,
ITGB7 💬
30件: Arrhythmogenic right ventricular cardiomyopathy, Axon guidance, Bacterial invasion of epithelial cells, Cell adhesion molecules, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pertussis, Phagosome, Platelet activation, Proteoglycans in cancer, Rap1 signaling pathway, Regulation of actin cytoskeleton, Shigellosis, Small cell lung cancer, Tight junction, Toxoplasmosis, Transcriptional misregulation in cancer, Virion - Rotavirus, Yersinia infection 💬1件: 97 💬
253CART19----1件: 49 💬
254Carvedilol1件: Carvedilol2件: Carvedilol ,
Carvedilol phosphate 💬
5件: ADRA1A,
ADRA1B,
ADRA1D,
ADRB1,
ADRB2 💬
15件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬6件: 6, 46, 57, 86, 113, 210 💬
255Carvi extractum fluidum----1件: 97 💬
256CAS NO.: 7758-16-9----1件: 166 💬
257Cascade1件: Flufenoxuron---1件: 226 💬
258Casein1件: Casein---1件: 97 💬
259Casimersen1件: Casimersen1件: Casimersen 💬 1件: DMD 💬 5件: Arrhythmogenic right ventricular cardiomyopathy, Cytoskeleton in muscle cells, Dilated cardiomyopathy, Hypertrophic cardiomyopathy, Viral myocarditis 💬1件: 113 💬
260Caspofungin acetate1件: Caspofungin2件: Caspofungin acetate ,
Caspofungin 💬
--1件: 60 💬
261CAT-1004----1件: 113 💬
262CAT-354----1件: 97 💬
263Catapres ampoules1件: Clonidine2件: Clonidine ,
Clonidine hydrochloride 💬
3件: ADRA2A,
ADRA2B,
ADRA2C 💬
4件: Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬1件: 6 💬
264Catapresan 75, tabletten----1件: 65 💬
265Cathepsin S----1件: 53 💬
266Cathepsin S inhibitor----1件: 53 💬
267Catheter directed therapy----1件: 88 💬
268Catridecacog1件: Catridecacog1件: Catridecacog 💬 --2件: 97, 288 💬
269Caudal epidural injection with celestone----1件: 70 💬
270Caudal epidural injection with depomedrol----1件: 70 💬
271Caudal epidural injection with generic celestone----1件: 70 💬
272Cavosonstat1件: Cavosonstat1件: Cavosonstat 💬 --1件: 299 💬
273Cawthorne cooksey exercises----1件: 13 💬
274Cayston1件: Aztreonam2件: Aztreonam ,
Aztreonam lysine 💬
--1件: 299 💬
275Cayston 75 MG pulver UND Lösungsmittel ZUR herstellung einer Lösung FüR einen vernebler1件: Aztreonam2件: Aztreonam ,
Aztreonam lysine 💬
--1件: 299 💬
276Cayston aztreonam 75 MG powder and solvent FOR nebuliser solution1件: Aztreonam2件: Aztreonam ,
Aztreonam lysine 💬
--1件: 299 💬
277CB-01-02----1件: 97 💬
278CB-01-05-MMX----1件: 97 💬
279CB-0101件: CB-010---1件: 49 💬
280CB-280----1件: 299 💬
281CBC----1件: 49 💬
282CBD----9件: 6, 8, 13, 36, 140, 144, 145, 156, 158 💬
283CBD - oral solution, IS known AS epidyolex, and IS THE approved name1件: Cannabidiol1件: Cannabidiol 💬 2件: CNR1,
CNR2 💬
4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬1件: 156 💬
284CBD - solution orale, conosciuto come epidiolex, questo è IL nome approvato negli stati uniti1件: Cannabidiol1件: Cannabidiol 💬 2件: CNR1,
CNR2 💬
4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬1件: 156 💬
285CBD OIL----1件: 51 💬
286CBD oral solution----1件: 206 💬
287CBD oral solution, IS known AS epidyolex and IS THE approved name IN THE EU1件: Cannabidiol1件: Cannabidiol 💬 2件: CNR1,
CNR2 💬
4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬1件: 156 💬
288CBD soluzione orale nota come epidyolex E CON tale nome è stato approvato IN UE1件: Cannabidiol1件: Cannabidiol 💬 2件: CNR1,
CNR2 💬
4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬1件: 156 💬
289CBD, synthetic form----1件: 97 💬
290CBD: GT4 transdermal delivery system----2件: 140, 144 💬
291Cbdca1件: Carboplatin1件: Carboplatin 💬 --1件: 85 💬
292Cbdv compound1件: Cannabidivarin---1件: 193 💬
293CBN----1件: 36 💬
294CBP-307----1件: 97 💬
295CBT and sleep hygiene----1件: 6 💬
296CBT102-A capsule----1件: 240 💬
297CC-100004----1件: 84 💬
298CC-10004----5件: 46, 56, 97, 162, 271 💬
299CC-220----1件: 49 💬
300CC-220 0.3 MG daily----1件: 84 💬
301CC-220 0.6MG daily----1件: 84 💬
302CC-292----1件: 46 💬
303CC-4047----2件: 28, 51 💬
304CC-5013----2件: 28, 96 💬
305CC-900011件: CC-90001---1件: 85 💬
306CC-930----1件: 85 💬
307CC-93538----1件: 98 💬
308CC-97540----4件: 11, 13, 49, 51 💬
309CC-99677----1件: 271 💬
310CC-99677 30MG capsule----1件: 271 💬
311CC-99677 60MG capsule----1件: 271 💬
312CC100----1件: 2 💬
313CC312----5件: 46, 49, 51, 61, 63 💬
314CCD 1042, MD 9150000, mepalon 1042, SPT316----2件: 152, 206 💬
315CCD 1042, MD 9150000, mepalon 1042, SPT3162----1件: 152 💬
316CCI-779----2件: 13, 46 💬
317CCP-020----1件: 36 💬
318CCR1 antagonist----1件: 46 💬
319CCX 354-C----1件: 46 💬
320CCX-354-C1件: CCX-354---1件: 46 💬
321CCX140-B----1件: 222 💬
322CCX168----6件: 43, 44, 49, 66, 109, 222 💬
323CCX282-B----1件: 96 💬
324CCX354-C----1件: 46 💬
325CD-4 guided therapy interruption----1件: 265 💬
326CD-C-food----1件: 96 💬
327CD-LD CR----1件: 6 💬
328CD-LD IR----1件: 6 💬
329CD19 CAR-T cell infusion----1件: 49 💬
330CD19 CAR-T cells----1件: 49 💬
331CD19 targeted CAR-T cells----3件: 50, 51, 53 💬
332CD19 universal CAR-?D T cells----1件: 49 💬
333CD19 universal CAR-T cells----1件: 49 💬
334CD19- bcma CAR-T cells----4件: 43, 49, 51, 53 💬
335CD19-bcma CAR-T cells infusion----3件: 49, 51, 53 💬
336CD19-bcma targeted CAR-T dose 1----1件: 11 💬
337CD19-bcma targeted CAR-T dose 2----1件: 11 💬
338CD19-CAR-DNT cells----2件: 49, 51 💬
339CD19-directed humanised afucosylated monoclonal antibody----1件: 11 💬
340CD19-targetd CAR-T----1件: 50 💬
341CD19/bcma CAR T-cells----2件: 16, 61 💬
342CD19/bcma CAR-T cell therapy----1件: 49 💬
343CD20/BCMA-directed CAR-T cells----3件: 11, 13, 49 💬
344CD3-depleted hematopoietic cell transplantation----1件: 60 💬
345CD3/CD19 depleted leukocytes----1件: 284 💬
346CD3/CD19 NEG allogeneic BMT----1件: 65 💬
347CD3/CD19 negative allogeneic hematopoietic stem cells----1件: 65 💬
348CD3/CD19 negative hematopoietic stem cells----1件: 85 💬
349CD34 selected autologous hematopoietic cells----1件: 51 💬
350CD34 selected haploidentical pbsct----1件: 285 💬
351CD34 stem cell selection therapy----3件: 60, 65, 284 💬
352CD34+ bone marrow stem cells intravitreal----1件: 90 💬
353CD34+ cell enriched stem cell graft----2件: 65, 285 💬
354CD34+ cells----1件: 285 💬
355CD34+ cells enriched with MNV-BLD----1件: 21 💬
356CD34+ enriched, T cell depleted donor stem cell product----1件: 326 💬
357CD34+ hscs transduced with THE lentivirus vector, VSV-G pseudotyped CL20-4I-EF1A-H?C-OPT----1件: 65 💬
358CD34+ peripheral blood stem cell reinfusion----1件: 49 💬
359CD34+ selected cells----1件: 285 💬
360CD34+cells----2件: 65, 285 💬
361CD34+SC----1件: 51 💬
362CD3±CD19 depleted hematopoietic stem cell transplantation----1件: 60 💬
363CD4-IGG----1件: 63 💬
364CD45RA depleted leukocytes----1件: 284 💬
365CD45RA-depleted DLI----1件: 60 💬
366CD62L- TEM----1件: 60 💬
367CD7 CAR T-cells----3件: 50, 96, 97 💬
368CD7 CAR-T cells injection----1件: 60 💬
369Cdca weight-based dose TID1件: Chenodeoxycholic acid1件: Chenodiol 💬 1件: NR1H4 💬 1件: Bile secretion 💬1件: 263 💬
370Cded (crohn'S disease exclusion diet) IN addition TO ANTI-TNF therapy----2件: 96, 97 💬
371Cded+dairy----1件: 96 💬
372Cded+PEN----1件: 96 💬
373Cdmard----1件: 46 💬
374Cdnf----1件: 6 💬
375CDP 6038 SC----1件: 46 💬
376CDP3194----1件: 49 💬
377CDP3231件: CDP323---1件: 13 💬
378CDP6038----2件: 46, 96 💬
379CDP7657----1件: 49 💬
380CDP870----3件: 46, 96, 271 💬
381CDP870 100MG----1件: 46 💬
382CDP870 200MG----1件: 46 💬
383CDP870 400MG----1件: 46 💬
384CDP870 FAB'-PEG----1件: 46 💬
385CDX 6114----1件: 240 💬
386CDX-0159----1件: 98 💬
387CDX-11351件: CDX-1135---1件: 222 💬
388CDZ173----2件: 53, 65 💬
389CE 224,535----1件: 46 💬
390CE-224,535----1件: 46 💬
391CE-VST01-JC1件: CE-VST01-JC---1件: 25 💬
392CE1145----1件: 65 💬
393Cebion 500*20CPR mast 500MG----1件: 10 💬
394Cebion 500MG 20CPR mast.aran----1件: 10 💬
395Cebsulfase alfa----1件: 19 💬
396Cediranib maleate1件: Cediranib2件: Cediranib ,
Cediranib maleate 💬
3件: FLT1,
FLT4,
KDR 💬
14件: Breast cancer, Calcium signaling pathway, Fluid shear stress and atherosclerosis, Focal adhesion, HIF-1 signaling pathway, MAPK signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Rheumatoid arthritis, Transcriptional misregulation in cancer, VEGF signaling pathway 💬1件: 34 💬
397Cefalexin1件: Cephalexin2件: Cefalexin ,
Cephalexin 💬
--1件: 299 💬
398Cefazolin1件: Cefazolin2件: Cefazolin sodium ,
Cefazolin 💬
--1件: 291 💬
399Cefazolina qilu1件: Cefazolin2件: Cefazolin sodium ,
Cefazolin 💬
--1件: 90 💬
400Cefepime dihydrochloride monohydrate1件: Cefepime2件: Cefepime hydrochloride ,
Cefepime 💬
--1件: 60 💬
401Cefiderocol1件: Cefiderocol2件: Cefiderocol sulfate tosylate ,
Cefiderocol 💬
--1件: 299 💬
402Cefoperazone1件: Cefoperazone2件: Cefoperazone sodium ,
Cefoperazone 💬
--1件: 296 💬
403Ceftaroline1件: Ceftaroline fosamil1件: Ceftaroline fosamil 💬 --1件: 299 💬
404Ceftazidim fresenius kabi 2000 MG poeder voor oplossing voor injectie OF infusie1件: Ceftazidime2件: Ceftazidime ,
Ceftazidime 💬
--1件: 299 💬
405Ceftazidima pentaidrato1件: Ceftazidime2件: Ceftazidime ,
Ceftazidime 💬
--1件: 299 💬
406Ceftazidime1件: Ceftazidime2件: Ceftazidime ,
Ceftazidime 💬
--1件: 299 💬
407Ceftazidime and tobramycin1件: Ceftazidime2件: Ceftazidime ,
Ceftazidime 💬
--1件: 299 💬
408Ceftazidime pentahydrate1件: Ceftazidime2件: Ceftazidime ,
Ceftazidime 💬
--1件: 299 💬
409Ceftazidime/avibactam1件: Ceftazidime2件: Ceftazidime ,
Ceftazidime 💬
--1件: 299 💬
410Ceftolozane/tazobactam1件: Ceftolozane2件: Ceftolozane ,
Ceftolozane sulfate 💬
--1件: 299 💬
411Ceftriaxone1件: Ceftriaxone2件: Ceftriaxone sodium ,
Ceftriaxone 💬
--3件: 2, 6, 97 💬
412Cefuroxim1件: Cefuroxime3件: Cefuroxime ,
Cefuroxime axetil ,
Cefuroxime sodium 💬
--1件: 299 💬
413Cefuroxima1件: Cefuroxime3件: Cefuroxime ,
Cefuroxime axetil ,
Cefuroxime sodium 💬
--1件: 90 💬
414Cefuroxime1件: Cefuroxime3件: Cefuroxime ,
Cefuroxime axetil ,
Cefuroxime sodium 💬
--2件: 97, 299 💬
415Celebra----1件: 46 💬
416Celebrex1件: Celecoxib1件: Celecoxib 💬 1件: PTGS2 💬 22件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬4件: 46, 96, 107, 271 💬
417Celebrex 200 MG----1件: 46 💬
418Celebrex 200 MG capsule, hard1件: Celecoxib1件: Celecoxib 💬 1件: PTGS2 💬 22件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬1件: 46 💬
419Celebrex 200 MG hartkapseln1件: Celecoxib1件: Celecoxib 💬 1件: PTGS2 💬 22件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬1件: 46 💬
420Celebrex 200MG 20CPS1件: Celecoxib1件: Celecoxib 💬 1件: PTGS2 💬 22件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬1件: 46 💬
421Celebrex 200MG capsule----1件: 70 💬
422Celebrex, celcox1件: Celecoxib1件: Celecoxib 💬 1件: PTGS2 💬 22件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬1件: 2 💬
423Celecoxib1件: Celecoxib1件: Celecoxib 💬 1件: PTGS2 💬 22件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬13件: 2, 3, 13, 34, 46, 70, 89, 96, 97, 107, 161, 171, 271 💬
424Celecoxib 200 milligrams1件: Celecoxib1件: Celecoxib 💬 1件: PTGS2 💬 22件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬1件: 271 💬
425Celecoxib 200MG1件: Celecoxib1件: Celecoxib 💬 1件: PTGS2 💬 22件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬1件: 6 💬
426Celecoxib 200MG capsule1件: Celecoxib1件: Celecoxib 💬 1件: PTGS2 💬 22件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬1件: 46 💬
427Celecoxib 400 milligrams1件: Celecoxib1件: Celecoxib 💬 1件: PTGS2 💬 22件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬1件: 271 💬
428Celiac block with triamcinolone and bupivicaine----1件: 298 💬
429Celiprolol1件: Celiprolol2件: Celiprolol hydrochloride ,
Celiprolol 💬
1件: ADRB1 💬 13件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 168 💬
430Cell infusion----3件: 60, 62, 283 💬
431Cell suspension containing dendritic cells----1件: 13 💬
432Cell transplantation----1件: 36 💬
433CELL-based EX-vivo assay with HIGH-content analysis----1件: 41 💬
434CELL-based therapeutics----1件: 2 💬
435CELL-based therapy----1件: 2 💬
436CELL-based therapy OF autologous adipose derived regenerative cells transplanted intraspinally and intrathecally IN ALS patients----1件: 2 💬
437Cellavita HD higher dose----1件: 8 💬
438Cellavita HD lower dose----1件: 8 💬
439Cellavita-HD----1件: 8 💬
440Cellcept1件: Mycophenolate mofetil2件: Mycophenolate mofetil ,
Mycophenolate mofetil hydrochloride 💬
2件: IMPDH,
IMPDH 💬
2件: Drug metabolism - other enzymes, Purine metabolism 💬5件: 11, 13, 42, 43, 49 💬
441Cellcept 500 MG----1件: 11 💬
442Cellcept 500 MG comprimidos recubiertos----1件: 35 💬
443Cellcept 500 MG FILM-coated tablets1件: Mycophenolate mofetil2件: Mycophenolate mofetil ,
Mycophenolate mofetil hydrochloride 💬
2件: IMPDH,
IMPDH 💬
2件: Drug metabolism - other enzymes, Purine metabolism 💬1件: 11 💬
444Cellcept 500 MG tablets1件: Mycophenolate mofetil2件: Mycophenolate mofetil ,
Mycophenolate mofetil hydrochloride 💬
2件: IMPDH,
IMPDH 💬
2件: Drug metabolism - other enzymes, Purine metabolism 💬1件: 11 💬
445Cellcept® IN autoimmune bullous dermatoses----2件: 35, 162 💬
446Cellcept®500 MG comprimidos----1件: 35 💬
447Cellcept®500 MG tablets1件: Mycophenolate mofetil2件: Mycophenolate mofetil ,
Mycophenolate mofetil hydrochloride 💬
2件: IMPDH,
IMPDH 💬
2件: Drug metabolism - other enzymes, Purine metabolism 💬1件: 11 💬
448Cellular senescence----1件: 46 💬
449Cellular therapy with EBV specific autologous CTL infusion----1件: 13 💬
450Cellule CD34+ autologhe trasdotte CON idua LV codificante PER IL cdna dell'ALFA-L-iduronidasi----1件: 19 💬
451Cellulose1件: Microcrystalline cellulose2件: Microcrystalline cellulose ,
Rayon, purified 💬
--1件: 84 💬
452Cellulose acetate with petrolatum1件: Microcrystalline cellulose2件: Microcrystalline cellulose ,
Rayon, purified 💬
--2件: 35, 162 💬
453Cellvizio 100 series system with confocal miniprobes----1件: 215 💬
454Celulas hepatocitos troncales adultas alogenicas DE higado expandidas----1件: 251 💬
455Celulas madre mesenquimales troncales adultas alogenicas DE Médula óSEA NO expandida----1件: 274 💬
456Cemdisiran1件: Cemdisiran---4件: 11, 62, 66, 109 💬
457Cendakimab1件: Cendakimab1件: Cendakimab 💬 1件: IL13 💬 8件: Asthma, Cytokine-cytokine receptor interaction, Fc epsilon RI signaling pathway, IL-17 signaling pathway, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation 💬1件: 98 💬
458Cenegermin1件: Cenegermin1件: Cenegermin 💬 1件: NGFR 💬 9件: Apoptosis - multiple species, Cytokine-cytokine receptor interaction, MAPK signaling pathway, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Rap1 signaling pathway, Ras signaling pathway, Transcriptional misregulation in cancer, Virion - Ebolavirus, Lyssavirus and Morbillivirus 💬1件: 53 💬
459Cenerimod1件: Cenerimod1件: Cenerimod 💬 1件: S1PR1 💬 4件: Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬1件: 49 💬
460Cenerimod 0.5 MG1件: Cenerimod1件: Cenerimod 💬 1件: S1PR1 💬 4件: Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬1件: 49 💬
461Cenerimod 1 MG1件: Cenerimod1件: Cenerimod 💬 1件: S1PR1 💬 4件: Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬1件: 49 💬
462Cenerimod 2 MG1件: Cenerimod1件: Cenerimod 💬 1件: S1PR1 💬 4件: Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬1件: 49 💬
463Cenerimod 4 MG1件: Cenerimod1件: Cenerimod 💬 1件: S1PR1 💬 4件: Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬1件: 49 💬
464Cenicriviroc 150 MG1件: Cenicriviroc2件: Cenicriviroc ,
Cenicriviroc mesylate 💬
2件: CCR2,
CCR5 💬
11件: Chemokine signaling pathway, Cytokine-cytokine receptor interaction, Endocytosis, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Toxoplasmosis, Viral carcinogenesis, Viral life cycle - HIV-1, Viral protein interaction with cytokine and cytokine receptor, Virion - Human immunodeficiency virus 💬1件: 94 💬
465Cenplacel-L1件: Cenplacel-L1件: Cenplacel-L 💬 --1件: 84 💬
466Censavudine1件: Censavudine1件: Censavudine 💬 --3件: 2, 127, 325 💬
467Centerpiece titanium plate----1件: 70 💬
468Centricyte 1000----2件: 85, 229 💬
469CEP-1347 10MG1件: CEP-1347---1件: 6 💬
470CEP-1347 50MG1件: CEP-1347---1件: 6 💬
471CEP-33457----1件: 49 💬
472CEP1347 25MG----1件: 6 💬
473Cephalexin1件: Cephalexin2件: Cefalexin ,
Cephalexin 💬
--1件: 299 💬
474Cepharanthin1件: Cepharanthine1件: Cepharanthine 💬 --1件: 53 💬
475Cepharanthine1件: Cepharanthine1件: Cepharanthine 💬 --1件: 53 💬
476CER-0011件: CER-001---1件: 79 💬
477Ceralifimod1件: Ceralifimod---1件: 13 💬
478Ceralifmod----1件: 13 💬
479Ceramic ON ceramic articulation----1件: 46 💬
480Ceramic ON polyethylene articulation----1件: 46 💬
481Cerazette----1件: 230 💬
482CERC-006----1件: 278 💬
483Cerdelga1件: Eliglustat2件: Eliglustat ,
Eliglustat tartrate 💬
1件: UGCG 💬 2件: Cornified envelope formation, Sphingolipid metabolism 💬1件: 19 💬
484CERE-1201件: CERE-120---1件: 6 💬
485CERE-120: AAV2-NTN1件: CERE-120---1件: 6 💬
486CERE-120: adeno-associated virus delivery OF neurturin1件: CERE-120---1件: 6 💬
487Cerebral dopamine neurotrophic factor1件: HER-902---1件: 6 💬
488Cerebro-spinal fluid----1件: 13 💬
489Cerebrolysin1件: Cerebrolysin---1件: 124 💬
490Ceretec (TM) estabilizado----1件: 6 💬
491Cerezyme1件: Imiglucerase2件: Alglucerase ,
Imiglucerase 💬
1件: GBA 💬 4件: Cornified envelope formation, Lysosome, Other glycan degradation, Sphingolipid metabolism 💬1件: 19 💬
492Cerezyme 400 units powder FOR concentrate FOR solution FOR infusion1件: Imiglucerase2件: Alglucerase ,
Imiglucerase 💬
1件: GBA 💬 4件: Cornified envelope formation, Lysosome, Other glycan degradation, Sphingolipid metabolism 💬1件: 19 💬
493Cerezyme 400 unità polvere PER concentrato PER soluzione PER infusione----1件: 19 💬
494Cerezyme® / imiglucerase1件: Imiglucerase2件: Alglucerase ,
Imiglucerase 💬
1件: GBA 💬 4件: Cornified envelope formation, Lysosome, Other glycan degradation, Sphingolipid metabolism 💬1件: 19 💬
495Cerliponase alfa1件: Cerliponase alfa1件: Cerliponase alfa 💬 1件: TPP1 💬 1件: Lysosome 💬1件: 19 💬
496Certican1件: Everolimus1件: Everolimus 💬 1件: MTOR 💬 49件: AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬3件: 67, 96, 228 💬
497Certican 0,5 MG tabletten1件: Everolimus1件: Everolimus 💬 1件: MTOR 💬 49件: AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬1件: 228 💬
498Certican 0,75MG tabletten1件: Everolimus1件: Everolimus 💬 1件: MTOR 💬 49件: AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬1件: 228 💬
499Certican 1 MG tablets1件: Everolimus1件: Everolimus 💬 1件: MTOR 💬 49件: AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬1件: 158 💬
500Certican tabletten1件: Everolimus1件: Everolimus 💬 1件: MTOR 💬 49件: AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬1件: 67 💬
501Certolizumab----4件: 46, 96, 270, 271 💬
502Certolizumab pegol1件: Certolizumab pegol1件: Certolizumab pegol 💬 1件: TNF 💬 66件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬7件: 37, 46, 49, 96, 107, 226, 271 💬
503Certolizumab pegol (CZP) 200 MG1件: Certolizumab pegol1件: Certolizumab pegol 💬 1件: TNF 💬 66件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46 💬
504Certolizumab pegol (CZP) 400 MG1件: Certolizumab pegol1件: Certolizumab pegol 💬 1件: TNF 💬 66件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46 💬
505Certolizumab pegol / cimzia1件: Certolizumab pegol1件: Certolizumab pegol 💬 1件: TNF 💬 66件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 271 💬
506Certolizumab pegol /cimzia1件: Certolizumab pegol1件: Certolizumab pegol 💬 1件: TNF 💬 66件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 96 💬
507Certolizumab pegol 400 MG1件: Certolizumab pegol1件: Certolizumab pegol 💬 1件: TNF 💬 66件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 96 💬
508Certolizumabpegol injection----1件: 46 💬
509Certoluzimab pegol----1件: 46 💬
510Cervarix suspensie voor injectie----3件: 49, 50, 107 💬
511Cervical interbody fusion----1件: 70 💬
512Ceterizine----1件: 13 💬
513Cetirizina1件: Cetirizine2件: Cetirizine hydrochloride ,
Cetirizine 💬
1件: HRH1 💬 4件: Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬2件: 300, 309 💬
514Cetirizina dicloridrato1件: Cetirizine2件: Cetirizine hydrochloride ,
Cetirizine 💬
1件: HRH1 💬 4件: Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬1件: 28 💬
515Cetirizina mylan generics1件: Cetirizine2件: Cetirizine hydrochloride ,
Cetirizine 💬
1件: HRH1 💬 4件: Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬1件: 13 💬
516Cetirizine1件: Cetirizine2件: Cetirizine hydrochloride ,
Cetirizine 💬
1件: HRH1 💬 4件: Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬3件: 13, 19, 35 💬
517Cetirizine hydrochloride1件: Cetirizine2件: Cetirizine hydrochloride ,
Cetirizine 💬
1件: HRH1 💬 4件: Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬1件: 13 💬
518Cetrizine----1件: 13 💬
519Cetrorelix1件: Cetrorelix2件: Cetrorelix acetate ,
Cetrorelix 💬
1件: GNRHR 💬 3件: GnRH signaling pathway, Hormone signaling, Neuroactive ligand-receptor interaction 💬1件: 46 💬
520Cetuximab1件: Cetuximab1件: Cetuximab 💬 1件: EGFR 💬 47件: Adherens junction, Bladder cancer, Breast cancer, Calcium signaling pathway, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Coronavirus disease - COVID-19, Cushing syndrome, Endocytosis, Endometrial cancer, Epithelial cell signaling in Helicobacter pylori infection, ErbB signaling pathway, Estrogen signaling pathway, Focal adhesion, FoxO signaling pathway, Gap junction, Gastric cancer, Glioma, GnRH signaling pathway, HIF-1 signaling pathway, Hepatitis C, Hepatocellular carcinoma, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanoma, MicroRNAs in cancer, Non-small cell lung cancer, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Shigellosis, Virion - Hepatitis viruses 💬5件: 34, 51, 86, 89, 331 💬
521Cevidoplenib1件: Cevidoplenib---1件: 46 💬
522Cevimeline1件: Cevimeline2件: Cevimeline hydrochloride ,
Cevimeline 💬
1件: CHRM3 💬 12件: Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction 💬1件: 53 💬
523CF fatalism scale----1件: 299 💬
524CF patients with A G551D mutation and treated with ivacaftor----1件: 299 💬
525CF101----1件: 46 💬
526CF101 1 MG----1件: 46 💬
527CF101 2 MG----1件: 46 💬
528Cftr modulators----1件: 299 💬
529Cftr potentiator----1件: 299 💬
530CFZ533----4件: 11, 46, 49, 53 💬
531CFZ533 active - cohort 1----1件: 53 💬
532CFZ533 active - cohort 2----1件: 53 💬
533CFZ533 active - cohort 3----1件: 53 💬
534CFZ533 active -cohort 3----1件: 53 💬
535CGM/CKM----1件: 67 💬
536Cgmp protein----1件: 97 💬
537CGP 77116----1件: 13 💬
538CH-1504----1件: 46 💬
539CH-4051----1件: 46 💬
540Chadox1 NCOV-191件: AstraZeneca COVID-19 Vaccine---3件: 46, 51, 299 💬
541Chadox2 HAV----1件: 96 💬
542Challenge agent: capsaicin----1件: 19 💬
543Champix1件: Varenicline2件: Varenicline tartrate ,
Varenicline 💬
2件: CHRNA4,
CHRNB2 💬
5件: Chemical carcinogenesis - receptor activation, Cholinergic synapse, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction 💬1件: 6 💬
544Characterization, evaluation and comparison OF macular pigment density----1件: 264 💬
545Charcoal----1件: 13 💬
546Chelation----1件: 60 💬
547Chemically modified recombinant human sulfamidase----1件: 19 💬
548Chemotherapy----3件: 28, 60, 285 💬
549Chemotherapy agents----1件: 51 💬
550Chemotherapy, intrathecal chemotherapy, steroid therapy----1件: 65 💬
551Chenodeoxycholic acid1件: Chenodeoxycholic acid1件: Chenodiol 💬 1件: NR1H4 💬 1件: Bile secretion 💬4件: 20, 96, 234, 263 💬
552Chenodeoxycholic acid leadiant1件: Chenodeoxycholic acid1件: Chenodiol 💬 1件: NR1H4 💬 1件: Bile secretion 💬1件: 263 💬
553Chenodiol1件: Chenodeoxycholic acid1件: Chenodiol 💬 1件: NR1H4 💬 1件: Bile secretion 💬1件: 96 💬
554Chenofalk----1件: 96 💬
555CHF 6333----1件: 299 💬
556CHF10067 high dose----1件: 85 💬
557CHF10067 intermediate dose----1件: 85 💬
558CHF10067 starting dose----1件: 85 💬
559CHF6333----1件: 299 💬
560CHF6657----1件: 19 💬
561Chicken type II collagen1件: Chicken---1件: 46 💬
562Childhood health assessment questionnaire----1件: 50 💬
563Chimeric fibril-reactive IGG1K monoclonal antibody 11-1f4----1件: 28 💬
564Chimeric fibril-reactive monoclonal ANTI-body 11-1f4----1件: 28 💬
565Chimeric human-murine IGG1 ----1件: 46 💬
566Chimeric human/mouse ANTI-CD-20 monoclonal antibody----1件: 46 💬
567Chimeric IGG1 monoclonal antibody----1件: 96 💬
568Chimeric monoclonal antibody, IGG4 subtype----2件: 43, 44 💬
569Chimeric murine human ANTI-IL-6 monoclonal antibody----1件: 331 💬
570Chinese herb prescription granule plus prednisone----1件: 66 💬
571Chinese herbal concoction twice A DAY FOR 6 months----1件: 60 💬
572Chinese herbal medicine treatment----1件: 6 💬
573Chinese herbal TEA tbdesjs----1件: 53 💬
574Chinese herbs based ON syndrome differentiation----1件: 224 💬
575Chlorhexidine1件: Chlorhexidine4件: Chlorhexidine gluconate ,
Chlorhexidine hydrochloride ,
Chlorhexidine ,
Chlorhexidine acetate 💬
--1件: 86 💬
576Chlorhexidine gluconate1件: Chlorhexidine4件: Chlorhexidine gluconate ,
Chlorhexidine hydrochloride ,
Chlorhexidine ,
Chlorhexidine acetate 💬
--1件: 299 💬
577Chlorhexidine gluconate oral rinse1件: Chlorhexidine4件: Chlorhexidine gluconate ,
Chlorhexidine hydrochloride ,
Chlorhexidine ,
Chlorhexidine acetate 💬
--1件: 299 💬
578Chloride1件: Chloride ion---1件: 97 💬
579Chlorogenic acid1件: Chlorogenic Acid---1件: 97 💬
580Chloroquine1件: Chloroquine4件: Chloroquine phosphate ,
Chloroquine ,
Chloroquine hydrochloride ,
Chloroquine sulfate 💬
--1件: 46 💬
581Chloroquine diphosphate1件: Chloroquine4件: Chloroquine phosphate ,
Chloroquine ,
Chloroquine hydrochloride ,
Chloroquine sulfate 💬
--1件: 95 💬
582Chloroquine diphosphate 250MG1件: Chloroquine4件: Chloroquine phosphate ,
Chloroquine ,
Chloroquine hydrochloride ,
Chloroquine sulfate 💬
--1件: 95 💬
583Chlorothiazide1件: Chlorothiazide2件: Chlorothiazide ,
Chlorothiazide sodium 💬
1件: SLC12A3 💬 1件: Parathyroid hormone synthesis, secretion and action 💬1件: 225 💬
584Chlorpromazine hydrochloride1件: Chlorpromazine2件: Chlorpromazine ,
Chlorpromazine hydrochloride 💬
13件: ADRA2A,
ADRA2B,
ADRA2C,
CHRM1,
CHRM2,
CHRM3,
CHRM4,
CHRM5,
DRD2,
HRH1,
HTR2,
HTR2,
HTR2 💬
24件: Alcoholism, Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Cocaine addiction, Dopaminergic synapse, Gap junction, Gastric acid secretion, Hormone signaling, Inflammatory mediator regulation of TRP channels, Insulin secretion, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Rap1 signaling pathway, Regulation of actin cytoskeleton, Salivary secretion, Serotonergic synapse, Taste transduction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 254 💬
585Chlorure DE sodium----1件: 96 💬
586Chocolate1件: Cocoa---1件: 6 💬
587Cholecalciferol1件: Cholecalciferol1件: Cholecalciferol 💬 1件: VDR 💬 5件: Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬9件: 13, 19, 34, 46, 49, 96, 97, 298, 299 💬
588Cholecalciferol 10,000 IU1件: Cholecalciferol1件: Cholecalciferol 💬 1件: VDR 💬 5件: Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬1件: 96 💬
589Cholecalciferol 400 IU1件: Cholecalciferol1件: Cholecalciferol 💬 1件: VDR 💬 5件: Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬1件: 96 💬
590Cholecalciferol and C. xanthorrhiza1件: Cholecalciferol1件: Cholecalciferol 💬 1件: VDR 💬 5件: Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬1件: 49 💬
591Cholecalciferol concentrate1件: Cholecalciferol1件: Cholecalciferol 💬 1件: VDR 💬 5件: Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬1件: 96 💬
592Cholecalciferol pill1件: Cholecalciferol1件: Cholecalciferol 💬 1件: VDR 💬 5件: Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬1件: 299 💬
593Cholecalciferol, vitamin D31件: Cholecalciferol1件: Cholecalciferol 💬 1件: VDR 💬 5件: Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬1件: 13 💬
594Cholestagel1件: Colesevelam2件: Colesevelam hydrochloride ,
Colesevelam 💬
--2件: 79, 96 💬
595Cholesterol1件: Cholesterol1件: Cholesterol 💬 --5件: 19, 90, 160, 222, 310 💬
596Cholesterol supplementation1件: Cholesterol1件: Cholesterol 💬 --1件: 310 💬
597Cholesterol suspension1件: Cholesterol1件: Cholesterol 💬 --1件: 310 💬
598Cholestyramine1件: Cholestyramine1件: Cholestyramine resin 💬 --2件: 13, 79 💬
599Cholic acid1件: Cholic Acid1件: Cholic acid 💬 1件: NR1H4 💬 1件: Bile secretion 💬4件: 20, 234, 265, 310 💬
600Cholic acids----2件: 20, 234 💬
601Choline chloride1件: Choline1件: Choline 💬 --1件: 299 💬
602Choline supplementation1件: Choline1件: Choline 💬 --1件: 299 💬
603Chondroitin sulfate1件: Chondroitin sulfate1件: Chondroitin sulfate A 💬 --1件: 96 💬
604Chong KUN dang tofacitinib tablet1件: Tofacitinib2件: Tofacitinib citrate ,
Tofacitinib 💬
4件: JAK1,
JAK2,
JAK3,
TYK2 💬
39件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, Efferocytosis, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Hormone signaling, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬1件: 46 💬
605CHOP-daclizumab----1件: 26 💬
606CHQ----1件: 50 💬
607CHR-1103 / GBR500----1件: 13 💬
608Chromium1件: Chromium---1件: 46 💬
609Chronic antioxidant----1件: 299 💬
610Chronic corticosteroid therapy----1件: 113 💬
611Chronic- PF-06480605 150 MG SC Q4W----1件: 97 💬
612Chronic- PF-06480605 450 MG SC Q4W----1件: 97 💬
613Chronic- PF-06480605 50 MG SC Q4W----1件: 97 💬
614Chronocort----1件: 81 💬
615Chronocort 10MG----1件: 81 💬
616Chronocort 5MG----1件: 81 💬
617Chronocort® 10 MG----1件: 81 💬
618Chronocort® 20 MG----1件: 81 💬
619Chronocort® 5 MG----1件: 81 💬
620CHS-0214----1件: 46 💬
621Chuna manipulation----1件: 70 💬
622Chuna manual medicine----1件: 70 💬
623CHX A-dtpa ANTI-CD66 antibody----1件: 28 💬
624CHX-A-DTPA-ANTI-CD66----1件: 28 💬
625CI-984----1件: 75 💬
626CI-984, 17aa70, PD 132301-2----1件: 81 💬
627Cialis1件: Tadalafil1件: Tadalafil 💬 1件: PDE5 💬 2件: Purine metabolism, cGMP-PKG signaling pathway 💬2件: 51, 86 💬
628Cialis - 20 MG 2 compresse rivestite CON film IN blister USO orale1件: Tadalafil1件: Tadalafil 💬 1件: PDE5 💬 2件: Purine metabolism, cGMP-PKG signaling pathway 💬2件: 75, 77 💬
629Cialis 10 MG FILM-coated tablets1件: Tadalafil1件: Tadalafil 💬 1件: PDE5 💬 2件: Purine metabolism, cGMP-PKG signaling pathway 💬2件: 86, 113 💬
630Cialis 2.5 MG FILM-coated tablets1件: Tadalafil1件: Tadalafil 💬 1件: PDE5 💬 2件: Purine metabolism, cGMP-PKG signaling pathway 💬2件: 86, 113 💬
631Cialis 20 MG comprimidos recubiertos CON PELícula1件: Tadalafil1件: Tadalafil 💬 1件: PDE5 💬 2件: Purine metabolism, cGMP-PKG signaling pathway 💬1件: 86 💬
632Cialis 20 MG FILM-coated tablets1件: Tadalafil1件: Tadalafil 💬 1件: PDE5 💬 2件: Purine metabolism, cGMP-PKG signaling pathway 💬2件: 86, 113 💬
633Cialis 5 MG FILM-coated tablets1件: Tadalafil1件: Tadalafil 💬 1件: PDE5 💬 2件: Purine metabolism, cGMP-PKG signaling pathway 💬2件: 86, 113 💬
634Cianocobalamina1件: Cyanocobalamin5件: Cyanocobalamin ,
Vitamin B12 ,
Cyanocobalamin Co 57 ,
Cyanocobalamin Co 58 ,
Cyanocobalamin Co 60 💬
--1件: 13 💬
635CIC----1件: 118 💬
636CIC using lofric primo----1件: 13 💬
637Ciclesonide1件: Ciclesonide1件: Ciclesonide 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 84 💬
638Cicletanine1件: Cicletanine2件: Cicletanine ,
Cicletanine hydrochloride 💬
--1件: 86 💬
639Cicletanine hydrochloride1件: Cicletanine2件: Cicletanine ,
Cicletanine hydrochloride 💬
--1件: 86 💬
640Ciclofosfamida1件: Cyclophosphamide2件: Cyclophosphamide ,
Cyclophosphamide 💬
--1件: 222 💬
641Ciclofosfamide1件: Cyclophosphamide2件: Cyclophosphamide ,
Cyclophosphamide 💬
--2件: 49, 51 💬
642Ciclosporin1件: Cyclosporine1件: Cyclosporine 💬 5件: PPP3C,
PPP3C,
PPP3C,
PPP3R,
PPP3R 💬
33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬12件: 26, 46, 49, 50, 53, 55, 60, 61, 97, 222, 226, 269 💬
643Ciclosporin A1件: Cyclosporine1件: Cyclosporine 💬 5件: PPP3C,
PPP3C,
PPP3C,
PPP3R,
PPP3R 💬
33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬1件: 228 💬
644Ciclosporin soft capsule1件: Cyclosporine1件: Cyclosporine 💬 5件: PPP3C,
PPP3C,
PPP3C,
PPP3R,
PPP3R 💬
33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬1件: 60 💬
645Ciclosporin soft capsules1件: Cyclosporine1件: Cyclosporine 💬 5件: PPP3C,
PPP3C,
PPP3C,
PPP3R,
PPP3R 💬
33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬1件: 222 💬
646Ciclosporina1件: Cyclosporine1件: Cyclosporine 💬 5件: PPP3C,
PPP3C,
PPP3C,
PPP3R,
PPP3R 💬
33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬3件: 49, 60, 97 💬
647Ciclosporina / ciclosporin1件: Cyclosporine1件: Cyclosporine 💬 5件: PPP3C,
PPP3C,
PPP3C,
PPP3R,
PPP3R 💬
33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬1件: 228 💬
648Ciclosporina A liposomica aerolised liposomal ciclosporin A1件: Cyclosporine1件: Cyclosporine 💬 5件: PPP3C,
PPP3C,
PPP3C,
PPP3R,
PPP3R 💬
33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬1件: 228 💬
649Ciclosporina/ ciclosporin1件: Cyclosporine1件: Cyclosporine 💬 5件: PPP3C,
PPP3C,
PPP3C,
PPP3R,
PPP3R 💬
33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬1件: 228 💬
650Ciclosporine1件: Cyclosporine1件: Cyclosporine 💬 5件: PPP3C,
PPP3C,
PPP3C,
PPP3R,
PPP3R 💬
33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬1件: 60 💬
651Ciclosporine A1件: Cyclosporine1件: Cyclosporine 💬 5件: PPP3C,
PPP3C,
PPP3C,
PPP3R,
PPP3R 💬
33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬1件: 228 💬
652Ciclosporine, ciclosporina1件: Cyclosporine1件: Cyclosporine 💬 5件: PPP3C,
PPP3C,
PPP3C,
PPP3R,
PPP3R 💬
33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬1件: 228 💬
653Cidofovir1件: Cidofovir1件: Cidofovir 💬 --1件: 25 💬
654Ciklosporin----1件: 226 💬
655Cilastatin1件: Cilastatin2件: Cilastatin sodium ,
Cilastatin 💬
--1件: 60 💬
656Cilazapril1件: Cilazapril2件: Cilazapril ,
Cilazapril 💬
1件: ACE 💬 6件: Chagas disease, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system 💬1件: 66 💬
657Ciliary neurotrophic factor implant NT-5011件: Ciliary neurotrophic factor---1件: 90 💬
658Cilnidipine1件: Cilnidipine1件: Cilnidipine 💬 5件: CACNA1B,
CACNA1C,
CACNA1D,
CACNA1F,
CACNA1S 💬
41件: Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Huntington disease, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Morphine addiction, Nicotine addiction, Oxytocin signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Synaptic vesicle cycle, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 67 💬
659Cilo----1件: 94 💬
660Cilofexor1件: Cilofexor---2件: 93, 94 💬
661Cilostazol1件: Cilostazol1件: Cilostazol 💬 3件: PDE3A,
PDE3B,
TBXA2R 💬
13件: Apelin signaling pathway, Calcium signaling pathway, Glucagon signaling pathway, Insulin signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Platelet activation, Progesterone-mediated oocyte maturation, Purine metabolism, Regulation of lipolysis in adipocytes, Renin secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬5件: 6, 46, 51, 70, 124 💬
662Cilostazol 100 MG1件: Cilostazol1件: Cilostazol 💬 3件: PDE3A,
PDE3B,
TBXA2R 💬
13件: Apelin signaling pathway, Calcium signaling pathway, Glucagon signaling pathway, Insulin signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Platelet activation, Progesterone-mediated oocyte maturation, Purine metabolism, Regulation of lipolysis in adipocytes, Renin secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 46 💬
663Ciltacabtagene autoleucel1件: Ciltacabtagene autoleucel1件: Ciltacabtagene autoleucel 💬 2件: CD38,
TNFRSF17 💬
8件: Calcium signaling pathway, Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, Intestinal immune network for IgA production, Nicotinate and nicotinamide metabolism, Oxytocin signaling pathway, Pancreatic secretion, Salivary secretion 💬1件: 28 💬
664Cimetidine1件: Cimetidine2件: Cimetidine ,
Cimetidine hydrochloride 💬
1件: HRH2 💬 4件: Calcium signaling pathway, Gastric acid secretion, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬1件: 254 💬
665Cimetidine plus dexpramipexole2件: Cimetidine,
Dexpramipexole
3件: Cimetidine ,
Cimetidine hydrochloride ,
Dexpramipexole 💬
6件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5,
HRH2 💬
14件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Gastric acid secretion, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 2 💬
666Cimzia1件: Certolizumab pegol1件: Certolizumab pegol 💬 1件: TNF 💬 66件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬6件: 46, 49, 96, 97, 107, 271 💬
667Cimzia 200 MG injeksjonsvæSKE, oppløsning----1件: 46 💬
668Cimzia 200 MG solution FOR injection1件: Certolizumab pegol1件: Certolizumab pegol 💬 1件: TNF 💬 66件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬3件: 46, 96, 271 💬
669Cimzia certolizumab pegol 200 MG/ML solution FOR injection1件: Certolizumab pegol1件: Certolizumab pegol 💬 1件: TNF 💬 66件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 271 💬
670Cinacalcet1件: Cinacalcet2件: Cinacalcet ,
Cinacalcet hydrochloride 💬
1件: CASR 💬 2件: NOD-like receptor signaling pathway, Parathyroid hormone synthesis, secretion and action 💬1件: 238 💬
671Cinryze----1件: 65 💬
672Cinryze 1000----1件: 65 💬
673Cinryze 1000 U----1件: 65 💬
674Cinryze 500----1件: 65 💬
675Cinryze 500 U----1件: 65 💬
676Cinryze with rhuph20----1件: 65 💬
677Cipaglucosidase alfa1件: Cipaglucosidase alfa1件: Cipaglucosidase alfa 💬 1件: GAA 💬 3件: Galactose metabolism, Lysosome, Starch and sucrose metabolism 💬1件: 256 💬
678Cipaglucosidasi alfa----1件: 256 💬
679Cipralex----1件: 6 💬
680Cipro inhale1件: Ciprofloxacin3件: Ciprofloxacin ,
Ciprofloxacin hydrochloride ,
Ciprofloxacin lactate 💬
--1件: 299 💬
681Cipro, ciprofloxacin1件: Ciprofloxacin3件: Ciprofloxacin ,
Ciprofloxacin hydrochloride ,
Ciprofloxacin lactate 💬
--1件: 2 💬
682Ciprofloxacin1件: Ciprofloxacin3件: Ciprofloxacin ,
Ciprofloxacin hydrochloride ,
Ciprofloxacin lactate 💬
--6件: 2, 46, 60, 96, 97, 299 💬
683Ciprofloxacin (BAYQ3939) DRY powder FOR inhalation1件: Ciprofloxacin3件: Ciprofloxacin ,
Ciprofloxacin hydrochloride ,
Ciprofloxacin lactate 💬
--1件: 299 💬
684Ciprofloxacin dispersion FOR inhalation1件: Ciprofloxacin3件: Ciprofloxacin ,
Ciprofloxacin hydrochloride ,
Ciprofloxacin lactate 💬
--1件: 299 💬
685Ciprofloxacin DPI1件: Ciprofloxacin3件: Ciprofloxacin ,
Ciprofloxacin hydrochloride ,
Ciprofloxacin lactate 💬
--1件: 299 💬
686Ciprofloxacin FOR inhalation1件: Ciprofloxacin3件: Ciprofloxacin ,
Ciprofloxacin hydrochloride ,
Ciprofloxacin lactate 💬
--1件: 299 💬
687Ciprofloxacin hydrochloride1件: Ciprofloxacin3件: Ciprofloxacin ,
Ciprofloxacin hydrochloride ,
Ciprofloxacin lactate 💬
--2件: 96, 299 💬
688Ciprofloxacin hydrochloride monohydrate1件: Ciprofloxacin3件: Ciprofloxacin ,
Ciprofloxacin hydrochloride ,
Ciprofloxacin lactate 💬
--1件: 299 💬
689Ciprofloxacin inhale1件: Ciprofloxacin3件: Ciprofloxacin ,
Ciprofloxacin hydrochloride ,
Ciprofloxacin lactate 💬
--1件: 299 💬
690Ciprofloxacina cloridrato----2件: 2, 299 💬
691Ciproxin----1件: 299 💬
692Ciproxin suspension----1件: 299 💬
693Ciproxin*6CPR RIV 500MG----1件: 299 💬
694Circadian rhythm measurement----1件: 106 💬
695Circadin1件: Melatonin1件: Melatonin 💬 2件: MTNR1A,
MTNR1B 💬
2件: Circadian entrainment, Neuroactive ligand-receptor interaction 💬1件: 13 💬
696Circadin 2 MG comprimidos DE liberacióN prolongada1件: Melatonin1件: Melatonin 💬 2件: MTNR1A,
MTNR1B 💬
2件: Circadian entrainment, Neuroactive ligand-receptor interaction 💬1件: 90 💬
697CIS-4-hydroxy-L-proline----1件: 94 💬
698Cisapride1件: Cisapride2件: Cisapride ,
Cisapride 💬
3件: HTR2,
HTR3,
HTR4 💬
8件: Calcium signaling pathway, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Serotonergic synapse, Taste transduction, cAMP signaling pathway 💬1件: 13 💬
699Cisplatin1件: Cisplatin1件: Cisplatin 💬 --1件: 28 💬
700Cistanche total glycosides----1件: 2 💬
701CIT-013 high dose----1件: 46 💬
702CIT-013 LOW dose----1件: 46 💬
703Citalopram1件: Citalopram2件: Citalopram hydrobromide ,
Citalopram 💬
1件: SLC6A4 💬 3件: Neuroactive ligand signaling, Serotonergic synapse, Synaptic vesicle cycle 💬5件: 6, 13, 46, 98, 127 💬
704Citalopram 20MG1件: Citalopram2件: Citalopram hydrobromide ,
Citalopram 💬
1件: SLC6A4 💬 3件: Neuroactive ligand signaling, Serotonergic synapse, Synaptic vesicle cycle 💬1件: 6 💬
705Citarabina1件: Cytarabine2件: Cytarabine ,
Cytarabine hydrochloride 💬
--1件: 13 💬
706Citicolin*1G/4ML IM IV 5 F----1件: 6 💬
707Citicolina 1000 MG/DIE1件: Citicoline2件: Citicoline ,
Citicoline sodium 💬
--1件: 6 💬
708Citicolina sodica1件: Citicoline2件: Citicoline ,
Citicoline sodium 💬
--1件: 6 💬
709Citochine ED immunomodulatori----1件: 13 💬
710Citocoline----1件: 205 💬
711Citric acid1件: Citric acid2件: Citric acid, anhydrous ,
Citric acid monohydrate 💬
--1件: 53 💬
712Citric acid based mouthwash1件: Citric acid2件: Citric acid, anhydrous ,
Citric acid monohydrate 💬
--1件: 53 💬
713Citrulline1件: Citrulline2件: L-Citrulline ,
Citrulline malate 💬
--1件: 113 💬
714CK-2017357----1件: 2 💬
715CK-21271071件: Reldesemtiv1件: Reldesemtiv 💬 3件: TNNC2,
TNNI2,
TNNT3 💬
3件: Calcium signaling pathway, Cytoskeleton in muscle cells, Motor proteins 💬1件: 2 💬
716CK-3773274----1件: 58 💬
717CK-3773274 - granules IN capsule----1件: 58 💬
718CK-3773274 - tablets----1件: 58 💬
719CK0803----1件: 2 💬
720CK2017357----1件: 2 💬
721CKD-5041件: CKD-504---1件: 8 💬
722CKD-506----1件: 46 💬
723CL20-I4-EF1A-H?C-OPT----1件: 65 💬
724CLA----2件: 13, 97 💬
725Cladribina1件: Cladribine1件: Cladribine 💬 1件: RRM1 💬 4件: Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬1件: 13 💬
726Cladribina oral1件: Cladribine1件: Cladribine 💬 1件: RRM1 💬 4件: Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬1件: 13 💬
727Cladribine1件: Cladribine1件: Cladribine 💬 1件: RRM1 💬 4件: Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬3件: 11, 13, 94 💬
728Cladribine 10 MG oral tablet1件: Cladribine1件: Cladribine 💬 1件: RRM1 💬 4件: Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬1件: 13 💬
729Cladribine 3.5 MG/KG1件: Cladribine1件: Cladribine 💬 1件: RRM1 💬 4件: Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬1件: 13 💬
730Cladribine 5.25 MG/KG1件: Cladribine1件: Cladribine 💬 1件: RRM1 💬 4件: Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬1件: 13 💬
731Cladribine high dose1件: Cladribine1件: Cladribine 💬 1件: RRM1 💬 4件: Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬1件: 11 💬
732Cladribine LOW dose1件: Cladribine1件: Cladribine 💬 1件: RRM1 💬 4件: Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬1件: 11 💬
733Cladribine oral tablet1件: Cladribine1件: Cladribine 💬 1件: RRM1 💬 4件: Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬1件: 13 💬
734Cladribine pill1件: Cladribine1件: Cladribine 💬 1件: RRM1 💬 4件: Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬1件: 13 💬
735Cladribine subcutaneous injection1件: Cladribine1件: Cladribine 💬 1件: RRM1 💬 4件: Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬1件: 13 💬
736Cladribine tablet1件: Cladribine1件: Cladribine 💬 1件: RRM1 💬 4件: Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬1件: 13 💬
737Cladribine tablets1件: Cladribine1件: Cladribine 💬 1件: RRM1 💬 4件: Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬1件: 13 💬
738Cladrybine----1件: 11 💬
739Clarithromycin1件: Clarithromycin1件: Clarithromycin 💬 --8件: 6, 46, 63, 84, 96, 97, 228, 299 💬
740Claritromycin 500MG film coated tablets----1件: 299 💬
741Clarium 50 MG retardtabletten----1件: 6 💬
742Clarix FLO----1件: 226 💬
743Clartihromycin, amoxicillin, and omeprazole----1件: 6 💬
744Classic dmards treatment group----1件: 46 💬
745Classic, progressive endurance training----1件: 13 💬
746Classical ketogenic diet----1件: 137 💬
747Clasteon----1件: 274 💬
748Clavulanic acid1件: Clavulanic acid2件: Clavulanate potassium ,
Clavulanic acid 💬
--1件: 299 💬
749Clazakizumab1件: Clazakizumab1件: Clazakizumab 💬 --1件: 46 💬
750CLBS121件: CLBS12---1件: 47 💬
751CLE----1件: 6 💬
752Clemastine1件: Clemastine2件: Clemastine fumarate ,
Clemastine 💬
1件: HRH1 💬 4件: Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬1件: 13 💬
753Clemastine fumarate1件: Clemastine2件: Clemastine fumarate ,
Clemastine 💬
1件: HRH1 💬 4件: Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬1件: 13 💬
754Clemastine fumarate tablets1件: Clemastine2件: Clemastine fumarate ,
Clemastine 💬
1件: HRH1 💬 4件: Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬1件: 179 💬
755Clemastine milstein 1 MG, tabletten1件: Clemastine2件: Clemastine fumarate ,
Clemastine 💬
1件: HRH1 💬 4件: Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬1件: 13 💬
756Clemizole HCL1件: Clemizole2件: Clemizole hydrochloride ,
Clemizole 💬
1件: TRPC5 💬 2件: Axon guidance, GnRH secretion 💬2件: 140, 144 💬
757Clemizole hydrochloride1件: Clemizole2件: Clemizole hydrochloride ,
Clemizole 💬
1件: TRPC5 💬 2件: Axon guidance, GnRH secretion 💬1件: 140 💬
758Clenbuterol1件: Clenbuterol2件: Clenbuterol hydrochloride ,
Clenbuterol 💬
1件: ADRB2 💬 11件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬4件: 1, 2, 113, 256 💬
759Clenbuterol HCL1件: Clenbuterol2件: Clenbuterol hydrochloride ,
Clenbuterol 💬
1件: ADRB2 💬 11件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 6 💬
760Clenbuterol hydrochloride1件: Clenbuterol2件: Clenbuterol hydrochloride ,
Clenbuterol 💬
1件: ADRB2 💬 11件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 6 💬
761Clenbuterolo----1件: 1 💬
762Clervonafusp alfa1件: Clervonafusp alfa1件: Clervonafusp alfa 💬 2件: GAA,
SLC29A1_2_3 💬
4件: Alcoholism, Galactose metabolism, Lysosome, Starch and sucrose metabolism 💬1件: 309 💬
763Clindamycin1件: Clindamycin4件: Clindamycin ,
Clindamycin phosphate ,
Clindamycin palmitate hydrochloride ,
Clindamycin hydrochloride 💬
--2件: 46, 299 💬
764Clinical and neurological evaluation----1件: 13 💬
765Clinical and neuropsychological assessments----1件: 6 💬
766Clinical assessment----2件: 6, 13 💬
767Clinical characteristics OF AMS patients----1件: 17 💬
768Clinical DBS setting----1件: 6 💬
769Clinical foot evaluation----1件: 46 💬
770Clinical laboratory evaluations - biochemistry----1件: 49 💬
771Clinical laboratory evaluations - hematology----1件: 49 💬
772Clinical laboratory evaluations - serology----1件: 49 💬
773Clinical observation----1件: 205 💬
774Clinican CBD 10% OIL----1件: 13 💬
775Clinimacs----2件: 60, 65 💬
776Clinimacs device----2件: 60, 285 💬
777Clinimacs prodigy system----1件: 285 💬
778Clinimacs® TCR A/ß reagent KIT and clinimacs® CD19 system----3件: 19, 96, 222 💬
779Clipper----1件: 97 💬
780CLN-978----1件: 49 💬
781Clobazam1件: Clobazam1件: Clobazam 💬 16件: GABRA,
GABRA,
GABRA,
GABRA,
GABRA,
GABRA,
GABRB,
GABRB,
GABRB,
GABRD,
GABRE,
GABRG,
GABRG,
GABRG,
GABRP,
GABRQ 💬
8件: GABAergic synapse, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬2件: 140, 144 💬
782Clobazam high dose1件: Clobazam1件: Clobazam 💬 16件: GABRA,
GABRA,
GABRA,
GABRA,
GABRA,
GABRA,
GABRB,
GABRB,
GABRB,
GABRD,
GABRE,
GABRG,
GABRG,
GABRG,
GABRP,
GABRQ 💬
8件: GABAergic synapse, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬1件: 144 💬
783Clobazam LOW dose1件: Clobazam1件: Clobazam 💬 16件: GABRA,
GABRA,
GABRA,
GABRA,
GABRA,
GABRA,
GABRB,
GABRB,
GABRB,
GABRD,
GABRE,
GABRG,
GABRG,
GABRG,
GABRP,
GABRQ 💬
8件: GABAergic synapse, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬1件: 144 💬
784Clobazam medium dose1件: Clobazam1件: Clobazam 💬 16件: GABRA,
GABRA,
GABRA,
GABRA,
GABRA,
GABRA,
GABRB,
GABRB,
GABRB,
GABRD,
GABRE,
GABRG,
GABRG,
GABRG,
GABRP,
GABRQ 💬
8件: GABAergic synapse, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬1件: 144 💬
785Clobazam tablets 10MG1件: Clobazam1件: Clobazam 💬 16件: GABRA,
GABRA,
GABRA,
GABRA,
GABRA,
GABRA,
GABRB,
GABRB,
GABRB,
GABRD,
GABRE,
GABRG,
GABRG,
GABRG,
GABRP,
GABRQ 💬
8件: GABAergic synapse, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬1件: 144 💬
786Clobazam tablets 20MG1件: Clobazam1件: Clobazam 💬 16件: GABRA,
GABRA,
GABRA,
GABRA,
GABRA,
GABRA,
GABRB,
GABRB,
GABRB,
GABRD,
GABRE,
GABRG,
GABRG,
GABRG,
GABRP,
GABRQ 💬
8件: GABAergic synapse, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬1件: 144 💬
787Clobazam tablets 5MG1件: Clobazam1件: Clobazam 💬 16件: GABRA,
GABRA,
GABRA,
GABRA,
GABRA,
GABRA,
GABRB,
GABRB,
GABRB,
GABRD,
GABRE,
GABRG,
GABRG,
GABRG,
GABRP,
GABRQ 💬
8件: GABAergic synapse, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬1件: 144 💬
788Clobetasol1件: Clobetasol1件: Clobetasol 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 51 💬
789Clobetasol 0.05% ointment1件: Clobetasol1件: Clobetasol 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 39 💬
790Clobetasol 0.05% topical ointment1件: Clobetasol1件: Clobetasol 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 162 💬
791Clobetasol decreasing measurement1件: Clobetasol1件: Clobetasol 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 162 💬
792Clobetasol propionate2件: Clobetasol,
Clobetasol propionate
2件: Clobetasol propionate ,
Clobetasol 💬
1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬2件: 46, 162 💬
793Clobetasol propionate + methotrexate2件: Clobetasol,
Clobetasol propionate
2件: Clobetasol propionate ,
Clobetasol 💬
1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 162 💬
794Clobetasol propionate alone2件: Clobetasol,
Clobetasol propionate
2件: Clobetasol propionate ,
Clobetasol 💬
1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 162 💬
795Clobetasol propionate cream treatment2件: Clobetasol,
Clobetasol propionate
2件: Clobetasol propionate ,
Clobetasol 💬
1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 162 💬
796Clobetasolo propionato----1件: 162 💬
797Clofarabine1件: Clofarabine1件: Clofarabine 💬 3件: POLA1,
POLA2,
RRM1 💬
5件: DNA replication, Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬5件: 19, 20, 60, 96, 234 💬
798Clofazimine1件: Clofazimine1件: Clofazimine 💬 --1件: 96 💬
799Clomiphene citrate1件: Clomifene2件: Clomiphene citrate ,
Clomifene 💬
2件: ESR1,
ESR2 💬
10件: Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Estrogen signaling pathway, GnRH secretion, Hormone signaling, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬2件: 74, 77 💬
800Clonazepam1件: Clonazepam1件: Clonazepam 💬 16件: GABRA,
GABRA,
GABRA,
GABRA,
GABRA,
GABRA,
GABRB,
GABRB,
GABRB,
GABRD,
GABRE,
GABRG,
GABRG,
GABRG,
GABRP,
GABRQ 💬
8件: GABAergic synapse, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬1件: 6 💬
801Clonidine1件: Clonidine2件: Clonidine ,
Clonidine hydrochloride 💬
3件: ADRA2A,
ADRA2B,
ADRA2C 💬
4件: Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬1件: 6 💬
802Clonidine hydrochloride1件: Clonidine2件: Clonidine ,
Clonidine hydrochloride 💬
3件: ADRA2A,
ADRA2B,
ADRA2C 💬
4件: Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬1件: 6 💬
803Clonidinhydrochlorid----1件: 65 💬
804Clopidogrel1件: Clopidogrel4件: Clopidogrel bisulfate ,
Clopidogrel ,
Clopidogrel hydrochloride ,
Clopidogrel besilate 💬
1件: P2RY12 💬 3件: Efferocytosis, Neuroactive ligand signaling, Platelet activation 💬4件: 40, 49, 51, 86 💬
805Clopidogrel treatment1件: Clopidogrel4件: Clopidogrel bisulfate ,
Clopidogrel ,
Clopidogrel hydrochloride ,
Clopidogrel besilate 💬
1件: P2RY12 💬 3件: Efferocytosis, Neuroactive ligand signaling, Platelet activation 💬1件: 51 💬
806Cloramfenicolo fisiopharma - 1 G/10 ML polvere E solvente PER soluzione iniettabile PER USO endovenoso 1 flaconcino polvere + 1 fiala solvente DA 10 ML----1件: 90 💬
807Clorfenamina maleato1件: Chlorpheniramine2件: Chlorpheniramine maleate ,
Chlorphenamine 💬
1件: HRH1 💬 4件: Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬1件: 14 💬
808Cloruro DI potassio----1件: 97 💬
809Cloruro DI sodio----1件: 97 💬
810Close follow-UP----2件: 58, 59 💬
811Clostridium botulinum toxin type A2件: Botulinum toxin type A,
Clostridium botulinum
2件: Botulinum toxin type A ,
Prabotulinumtoxin A 💬
1件: SNAP25 💬 2件: Insulin secretion, Synaptic vesicle cycle 💬1件: 13 💬
812Clotrimazole1件: Clotrimazole1件: Clotrimazole 💬 --1件: 97 💬
813Clozapine1件: Clozapine1件: Clozapine 💬 11件: ADRA2A,
ADRA2B,
ADRA2C,
DRD4,
HTR2,
HTR2,
HTR3,
HTR3,
HTR3,
HTR3,
HTR3 💬
10件: Calcium signaling pathway, Dopaminergic synapse, Gap junction, Hormone signaling, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Serotonergic synapse, Taste transduction, cGMP-PKG signaling pathway 💬1件: 6 💬
814CLS12311----1件: 13 💬
815CLS12311 high----1件: 13 💬
816CLS12311 LOW----1件: 13 💬
817CLS12311 medium----1件: 13 💬
818CLTX-305----1件: 235 💬
819Cluvot----1件: 288 💬
820CLZ-20021件: CLZ-2002---1件: 10 💬
821CM-1011件: CM-101---2件: 51, 94 💬
822CM-336 bcma/CD3 bispecific antibody----1件: 28 💬
823CM310----1件: 300 💬
824CM313----1件: 66 💬
825CM313 injection----3件: 35, 49, 63 💬
826CM313(SC) injection----1件: 60 💬
827CM336 injection----1件: 63 💬
828CM338----1件: 66 💬
829CMAB008----1件: 46 💬
830CME-LEM4----1件: 117 💬
831CMK389----1件: 84 💬
832CMR316----1件: 85 💬
833Cmri----3件: 51, 77, 86 💬
834CMS----1件: 299 💬
835CMTS0929----1件: 97 💬
836CMTX-101----1件: 299 💬
837CNCT19 CAR-T cell therapy----1件: 61 💬
838CNCT19 cell injection----1件: 49 💬
839CNM-AU81件: CNM-Au8---2件: 2, 13 💬
840Cnmau8----1件: 2 💬
841CNP-104----1件: 93 💬
842CNP-106----1件: 11 💬
843CNP-MS-0601----1件: 13 💬
844CNS10-NPC implantation----1件: 90 💬
845CNS10-NPC-gdnf----1件: 2 💬
846CNSA-001----1件: 240 💬
847CNT-02----1件: 160 💬
848Cnto 1275----2件: 13, 96 💬
849Cnto 136----2件: 41, 46 💬
850Cnto 136 100 MG----1件: 46 💬
851Cnto 136 25 MG----1件: 46 💬
852Cnto 136 50 MG----1件: 46 💬
853Cnto 136 IGG----1件: 46 💬
854Cnto 148----4件: 46, 84, 97, 271 💬
855Cnto 1959----1件: 46 💬
856Cnto 1959 IGG----1件: 46 💬
857Cnto 2476----1件: 90 💬
858Cnto 328----1件: 331 💬
859Cnto 6785 100 MG----1件: 46 💬
860Cnto 6785 15 MG----1件: 46 💬
861Cnto 6785 200 MG----1件: 46 💬
862Cnto 6785 50 MG----1件: 46 💬
863Cnto 888 1 MG/KG----1件: 85 💬
864Cnto 888 15 MG/KG----1件: 85 💬
865Cnto 888 5 MG/KG----1件: 85 💬
866CNTO-148----1件: 97 💬
867CNTO1275----6件: 46, 49, 84, 93, 96, 97 💬
868CNTO136----1件: 46 💬
869CNTO148----5件: 46, 84, 96, 97, 107 💬
870CNTO1959----4件: 37, 41, 96, 97 💬
871CNTO312----1件: 97 💬
872CNTO328----1件: 331 💬
873CNTO6785----1件: 46 💬
874CNTO888----1件: 85 💬
875CNTY-101----2件: 49, 51 💬
876CO-14----1件: 13 💬
877CO-medication: synthetic dmards----1件: 46 💬
878CO-transplantation OF FMT and pectin----1件: 97 💬
879CO-trimoxazole----1件: 85 💬
880CO2 laser----1件: 51 💬
881Coaching sessions----1件: 49 💬
882Coagadex----2件: 28, 288 💬
883CoagulacióN factor viii----1件: 288 💬
884Coagulation factor viii1件: Beroctocog alfa---1件: 288 💬
885Coagulation factor xiii1件: Factor XIII (human)---1件: 288 💬
886Coamoxiclav----1件: 97 💬
887Coarse wheat bran----1件: 6 💬
888Cobalt1件: Cobalt---1件: 46 💬
889Cobalt™ bone cement1件: Cobalt---1件: 46 💬
890Cobamamide1件: Cobamamide1件: Cobamamide 💬 --1件: 299 💬
891Cobimetinib1件: Cobimetinib2件: Cobimetinib ,
Cobimetinib fumarate 💬
2件: MAP2K1,
MAP2K2 💬
88件: Acute myeloid leukemia, Alcoholism, Alzheimer disease, Apelin signaling pathway, Apoptosis, Autophagy - animal, B cell receptor signaling pathway, Bladder cancer, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Choline metabolism in cancer, Cholinergic synapse, Chronic myeloid leukemia, Colorectal cancer, Cushing syndrome, Efferocytosis, Endometrial cancer, ErbB signaling pathway, Estrogen signaling pathway, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Focal adhesion, FoxO signaling pathway, Gap junction, Gastric cancer, Glioma, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatitis B, Hepatitis C, Hepatocellular carcinoma, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Influenza A, Insulin signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Long-term depression, Long-term potentiation, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Natural killer cell mediated cytotoxicity, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Non-small cell lung cancer, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Renal cell carcinoma, Salmonella infection, Serotonergic synapse, Signaling pathways regulating pluripotency of stem cells, Sphingolipid signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Thyroid cancer, Thyroid hormone signaling pathway, Toll-like receptor signaling pathway, VEGF signaling pathway, Vascular smooth muscle contraction, Yersinia infection, cAMP signaling pathway, cGMP-PKG signaling pathway, mTOR signaling pathway 💬1件: 280 💬
892Cobiprostone1件: Cobiprostone1件: Cobiprostone 💬 --1件: 46 💬
893Cobitolimod1件: Cobitolimod1件: Cobitolimod 💬 1件: TLR9 💬 9件: African trypanosomiasis, Chagas disease, Herpes simplex virus 1 infection, Malaria, Measles, PD-L1 expression and PD-1 checkpoint pathway in cancer, Salmonella infection, Toll-like receptor signaling pathway, Tuberculosis 💬1件: 97 💬
894Cobitolimod 250 MG1件: Cobitolimod1件: Cobitolimod 💬 1件: TLR9 💬 9件: African trypanosomiasis, Chagas disease, Herpes simplex virus 1 infection, Malaria, Measles, PD-L1 expression and PD-1 checkpoint pathway in cancer, Salmonella infection, Toll-like receptor signaling pathway, Tuberculosis 💬1件: 97 💬
895Cobitolimod 500 MG1件: Cobitolimod1件: Cobitolimod 💬 1件: TLR9 💬 9件: African trypanosomiasis, Chagas disease, Herpes simplex virus 1 infection, Malaria, Measles, PD-L1 expression and PD-1 checkpoint pathway in cancer, Salmonella infection, Toll-like receptor signaling pathway, Tuberculosis 💬1件: 97 💬
896Cobitolimod 500MG1件: Cobitolimod1件: Cobitolimod 💬 1件: TLR9 💬 9件: African trypanosomiasis, Chagas disease, Herpes simplex virus 1 infection, Malaria, Measles, PD-L1 expression and PD-1 checkpoint pathway in cancer, Salmonella infection, Toll-like receptor signaling pathway, Tuberculosis 💬1件: 97 💬
897Cocoa1件: Cocoa---1件: 6 💬
898Coconut OIL2件: Coconut,
Coconut oil
1件: Coconut oil 💬 --1件: 13 💬
899Coconut OIL and epigallocatechin gallate2件: Coconut,
Coconut oil
1件: Coconut oil 💬 --1件: 13 💬
900COD liver OIL1件: Cod liver oil1件: Cod liver oil 💬 --1件: 46 💬
901Code ATC:L01xc04----1件: 65 💬
902Coduse balance training and step square exercises----1件: 13 💬
903Coenzym Q10 nanodispersion----1件: 5 💬
904Coenzym Q10, ubiquinon, ubichinon----1件: 5 💬
905Coenzyme Q----1件: 13 💬
906Coenzyme Q-10 IN normal control subjects1件: Ubidecarenone1件: Ubidecarenone 💬 --1件: 86 💬
907Coenzyme Q-10 IN pulmonary hypertension subjects1件: Ubidecarenone1件: Ubidecarenone 💬 --1件: 86 💬
908Coenzyme Q101件: Ubidecarenone1件: Ubidecarenone 💬 --12件: 2, 5, 6, 8, 10, 46, 57, 107, 113, 193, 214, 215 💬
909Coenzyme Q10 and lisinopril1件: Ubidecarenone1件: Ubidecarenone 💬 --1件: 113 💬
910Coenzyme Q10 with vitamin E1件: Ubidecarenone1件: Ubidecarenone 💬 --1件: 6 💬
911Coenzymeq10----1件: 21 💬
912Coffee----1件: 96 💬
913Coffee coal----1件: 97 💬
914Coffee consumption----1件: 46 💬
915Cognitive and behavioral experimental tasks----1件: 127 💬
916Cognitive battery----1件: 6 💬
917Cognitive evaluation----1件: 8 💬
918Cognitive training----1件: 206 💬
919Cohort 1 0.225G----1件: 240 💬
920Cohort 1: 1.0 X 10^8 polytregs----1件: 35 💬
921Cohort 1: hatg, CSA, epag DAY 14 TO month 6----1件: 60 💬
922Cohort 1: JMKX003142 and itraconazole----1件: 67 💬
923Cohort 2 0.75G----1件: 240 💬
924Cohort 2: 2.5x10^8 polytregs----1件: 35 💬
925Cohort 2: hatg, CSA, epag DAY 14 TO month 3----1件: 60 💬
926Cohort 2: JMKX003142 and rifampicin----1件: 67 💬
927Cohort 3 2.25 G----1件: 240 💬
928Cohort 3: hatg, CSA (dose reduced), epag DAY 1 TO month 6----1件: 60 💬
929Cohort1----1件: 6 💬
930Cohort2----1件: 6 💬
931COL7a1-SIN retroviral vector engineered autologous tissue-engineered skin----1件: 36 💬
932Colal pred----1件: 97 💬
933Colal-pred----1件: 97 💬
934Colchicina lirca - 1 MG compresse 60 compresse1件: Colchicine1件: Colchicine 💬 9件: TUBB,
TUBB,
TUBB,
TUBB,
TUBB,
TUBB,
TUBB,
TUBB,
TUBB 💬
11件: Alzheimer disease, Amyotrophic lateral sclerosis, Gap junction, Huntington disease, Motor proteins, Parkinson disease, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Phagosome, Prion disease, Salmonella infection 💬1件: 2 💬
935Colchicine1件: Colchicine1件: Colchicine 💬 9件: TUBB,
TUBB,
TUBB,
TUBB,
TUBB,
TUBB,
TUBB,
TUBB,
TUBB 💬
11件: Alzheimer disease, Amyotrophic lateral sclerosis, Gap junction, Huntington disease, Motor proteins, Parkinson disease, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Phagosome, Prion disease, Salmonella infection 💬8件: 42, 46, 50, 56, 93, 97, 210, 266 💬
936Colchicine 1 MG oral tablet1件: Colchicine1件: Colchicine 💬 9件: TUBB,
TUBB,
TUBB,
TUBB,
TUBB,
TUBB,
TUBB,
TUBB,
TUBB 💬
11件: Alzheimer disease, Amyotrophic lateral sclerosis, Gap junction, Huntington disease, Motor proteins, Parkinson disease, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Phagosome, Prion disease, Salmonella infection 💬1件: 2 💬
937Colchicine cessation1件: Colchicine1件: Colchicine 💬 9件: TUBB,
TUBB,
TUBB,
TUBB,
TUBB,
TUBB,
TUBB,
TUBB,
TUBB 💬
11件: Alzheimer disease, Amyotrophic lateral sclerosis, Gap junction, Huntington disease, Motor proteins, Parkinson disease, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Phagosome, Prion disease, Salmonella infection 💬1件: 266 💬
938Colchicine level measurement1件: Colchicine1件: Colchicine 💬 9件: TUBB,
TUBB,
TUBB,
TUBB,
TUBB,
TUBB,
TUBB,
TUBB,
TUBB 💬
11件: Alzheimer disease, Amyotrophic lateral sclerosis, Gap junction, Huntington disease, Motor proteins, Parkinson disease, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Phagosome, Prion disease, Salmonella infection 💬1件: 266 💬
939Colchicine sprinkle capsules1件: Colchicine1件: Colchicine 💬 9件: TUBB,
TUBB,
TUBB,
TUBB,
TUBB,
TUBB,
TUBB,
TUBB,
TUBB 💬
11件: Alzheimer disease, Amyotrophic lateral sclerosis, Gap junction, Huntington disease, Motor proteins, Parkinson disease, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Phagosome, Prion disease, Salmonella infection 💬1件: 266 💬
940Cold cadioplegia----1件: 215 💬
941Colecalciferol1件: Cholecalciferol1件: Cholecalciferol 💬 1件: VDR 💬 5件: Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬5件: 13, 46, 96, 97, 228 💬
942Colectomy----1件: 97 💬
943Colesevelam1件: Colesevelam2件: Colesevelam hydrochloride ,
Colesevelam 💬
--1件: 96 💬
944Colesevelam hydrochloride1件: Colesevelam2件: Colesevelam hydrochloride ,
Colesevelam 💬
--1件: 79 💬
945Colesevelam hydrochloride FILM-coated tablets1件: Colesevelam2件: Colesevelam hydrochloride ,
Colesevelam 💬
--1件: 79 💬
946Colestipol1件: Colestipol2件: Colestipol hydrochloride ,
Colestipol 💬
--1件: 254 💬
947Colestiramina1件: Cholestyramine1件: Cholestyramine resin 💬 --1件: 13 💬
948Colestyramine1件: Cholestyramine1件: Cholestyramine resin 💬 --1件: 254 💬
949Colfinair 2 MIU powder FOR nebuliser solution----1件: 299 💬
950Colimicina - 1000000 U/4 ML polvere E solvente PER soluzione iniettabile PER USO intramuscolare1 flaconcino polvere + 1 fiala solvente 4 ML----1件: 299 💬
951Colimycine inhalation----1件: 299 💬
952Colimycine injectable----1件: 299 💬
953Colistimetato sodico----1件: 299 💬
954Colistimethat-natrium----1件: 299 💬
955Colistimethate1件: Colistimethate1件: Colistimethate sodium 💬 --1件: 299 💬
956Colistimethate 75 MG inhaled TWO times daily1件: Colistimethate1件: Colistimethate sodium 💬 --1件: 299 💬
957Colistimethate sodium1件: Colistimethate1件: Colistimethate sodium 💬 --1件: 299 💬
958Colistimethate sodium (BAN, usan), colistimethatum natricum, colistin sodium methanesulfonate1件: Colistimethate1件: Colistimethate sodium 💬 --1件: 299 💬
959Colistin1件: Colistin2件: Colistin sulfate ,
Colistin 💬
--1件: 299 💬
960Colistin CF1件: Colistin2件: Colistin sulfate ,
Colistin 💬
--1件: 299 💬
961Colistin forest - trockenstechampullen MIT Lösungsmittel1件: Colistin2件: Colistin sulfate ,
Colistin 💬
--1件: 299 💬
962Colistin mesilate sodium1件: Colistin2件: Colistin sulfate ,
Colistin 💬
--1件: 299 💬
963Colistineb 2MUI----1件: 299 💬
964Collagenase1件: Collagenase clostridium histolyticum1件: Collagenase clostridium histolyticum 💬 --1件: 162 💬
965Collect OF 10 ML OF peripheric blood FOR DNA extraction----1件: 46 💬
966Collection OF arterial pressure, metabolic data, kidney function, proteinuria and hematuria before and after katrio initiation----1件: 299 💬
967Collection OF biological samples----1件: 63 💬
968Collection OF blood and urine----1件: 25 💬
969Collection OF CSF, blood, urine, saliva----1件: 6 💬
970Collection OF samples----4件: 49, 65, 95, 107 💬
971Collection OF samples OF blood and urine----1件: 167 💬
972Colobreathe1件: Colistimethate1件: Colistimethate sodium 💬 --1件: 299 💬
973Colomycin----1件: 299 💬
974Colon KCC heptapeptide----1件: 97 💬
975Colon preparation FOR colonoscopy----1件: 97 💬
976Colonic lavage----1件: 291 💬
977Colonoscopy----2件: 96, 97 💬
978Colonoscopy with indigo-carmine chromoendoscopy----1件: 97 💬
979Color fundus photography----1件: 41 💬
980Colorectal biopsies----1件: 97 💬
981Colored water----1件: 97 💬
982Colovit capsule----1件: 96 💬
983Coltect----1件: 97 💬
984Combination antiviral therapy----1件: 93 💬
985Combination fish OIL and borage seed OIL1件: Fish oil---1件: 46 💬
986Combination injection OF EPO and G-CSF----1件: 6 💬
987Combination OF A single dose ANTI-CD20 antibody and bortezomib----1件: 61 💬
988Combination OF dmards----1件: 107 💬
989Combination OF fish OIL and colesevelam----1件: 260 💬
990Combination OF minocycline and MTX or MTX alone----1件: 46 💬
991Combination OF navepegritide and lonapegsomatropin administered AS TWO separate S.C. injections----1件: 276 💬
992Combination OF protein A immunoadsorption, rituximab, dexamethasone plus azathioprine----1件: 35 💬
993Combination OF rituximab with subcutaneous belimumab1件: Rituximab1件: Rituximab 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬1件: 63 💬
994Combination OF thrombopoietin mimetic and cyclosporin A----1件: 60 💬
995Combination oral budesonide and rectal hydrocortisone----1件: 97 💬
996Combination steroid----1件: 46 💬
997Combination therapy with vigabatrin and prednisolone1件: Vigabatrin1件: Vigabatrin 💬 1件: ABAT 💬 6件: Alanine, aspartate and glutamate metabolism, Butanoate metabolism, GABAergic synapse, Propanoate metabolism, Valine, leucine and isoleucine degradation, beta-Alanine metabolism 💬1件: 145 💬
998Combination with dopamine agonist cabergoline----1件: 77 💬
999Combination with somatostatin analogue octreotide----1件: 77 💬
1000Combined balance and brisk walking training----1件: 6 💬
1001Combined plasma exchange (PEX), rituximab, and corticosteroids----1件: 85 💬
1002Combined therapy OF iguratimod and tofacitinib----1件: 46 💬
1003Combivir2件: Lamivudine,
Zidovudine
2件: Lamivudine ,
Zidovudine 💬
--1件: 265 💬
1004Comirnaty----2件: 46, 51 💬
1005Comirnaty concentrate FOR dispersion FOR injection1件: Tozinameran1件: Tozinameran 💬 --2件: 53, 299 💬
1006Comirnaty konzentrat ZUR herstellung einer injektionsdispersion----1件: 13 💬
1007Commercial formulation etanercept----1件: 46 💬
1008Common name: sialic acid----1件: 30 💬
1009Communicative effectiveness survey----1件: 2 💬
1010Companion diagnostic (CDX) testing----1件: 97 💬
1011Comparative efficacy and safety OF thalidomide and sulfasalazine IN moderate TO severe ankylosing spondylitis: A REAL-world study from bangladesh----1件: 271 💬
1012Comparator----1件: 96 💬
1013Comparators----1件: 54 💬
1014Complement C1 esterase inhibitor1件: Conestat alfa1件: Conestat alfa 💬 3件: C1R,
C1S,
KLKB1 💬
6件: Complement and coagulation cascades, Coronavirus disease - COVID-19, Pertussis, Phagosome, Staphylococcus aureus infection, Systemic lupus erythematosus 💬2件: 61, 65 💬
1015Complement protein C5 inhibitor----1件: 13 💬
1016Complete physical examination----1件: 113 💬
1017Complete, polymeric formula, fiber, lactose and gluten free----1件: 107 💬
1018Complex task practice----1件: 6 💬
1019Compound 1A----2件: 246, 299 💬
1020Compound 211件: Buloxibutid2件: Buloxibutid ,
Buloxibutid sodium 💬
2件: AGTR1,
AGTR2 💬
17件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hormone signaling, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 85 💬
1021Compound thrombosis capsule SIG: 1.5G/TID----1件: 90 💬
1022Compressa effervescente 0,5 MG DI budesonide PER USO orodispersibile1件: Budesonide1件: Budesonide 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 98 💬
1023Compressa effervescente 1 MG DI budesonide PER USO orodispersibile1件: Budesonide1件: Budesonide 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 98 💬
1024Compressed oxygen1件: Oxygen1件: Oxygen 💬 --1件: 97 💬
1025Computed tomography----12件: 26, 28, 40, 46, 49, 60, 62, 65, 96, 284, 285, 286 💬
1026Computed tomography lung subtraction iodine mapping----1件: 88 💬
1027Computer game based balance and walking rehabilitation FOR individuals with parkinson'S disease----1件: 6 💬
1028Computer-assisted telephone interview----1件: 85 💬
1029Computerized tomography scan----1件: 98 💬
1030Comtan1件: Entacapone1件: Entacapone 💬 1件: COMT 💬 3件: Dopaminergic synapse, Steroid hormone biosynthesis, Tyrosine metabolism 💬1件: 6 💬
1031Comtan 200* 60 CPR 200 MG1件: Entacapone1件: Entacapone 💬 1件: COMT 💬 3件: Dopaminergic synapse, Steroid hormone biosynthesis, Tyrosine metabolism 💬1件: 6 💬
1032Comtess1件: Entacapone1件: Entacapone 💬 1件: COMT 💬 3件: Dopaminergic synapse, Steroid hormone biosynthesis, Tyrosine metabolism 💬1件: 6 💬
1033Concerta----1件: 203 💬
1034Concomitant medication----1件: 49 💬
1035Concurrent exercise training----1件: 113 💬
1036Conestat alfa1件: Conestat alfa1件: Conestat alfa 💬 3件: C1R,
C1S,
KLKB1 💬
6件: Complement and coagulation cascades, Coronavirus disease - COVID-19, Pertussis, Phagosome, Staphylococcus aureus infection, Systemic lupus erythematosus 💬1件: 65 💬
1037Confirm RX----1件: 86 💬
1038Confortid----1件: 225 💬
1039Conjugated equine estrogens 0.625 MG/D + MPA 5 MG/D/10D1件: Conjugated estrogens1件: Estrogens, conjugated 💬 --1件: 49 💬
1040Conscious sedation----1件: 6 💬
1041Conservative measures FOR orthostatic hypotension----2件: 6, 17 💬
1042Conservative rehabilitation----1件: 149 💬
1043Conservative treatment----1件: 291 💬
1044Continuation OF azathioprine----1件: 49 💬
1045Continue their usual therapy----1件: 66 💬
1046Continued ocrelizumab----1件: 13 💬
1047Continuous apomorphine infusion----1件: 6 💬
1048Continuous glucose monitor----2件: 65, 298 💬
1049Continuous glucose monitoring1件: Dextrose, unspecified form2件: Dextrose ,
Glucose, liquid 💬
--2件: 75, 299 💬
1050Continuous infusion cefepime----1件: 299 💬
1051Continuous infusion ceftazidime----1件: 299 💬
1052Continuous infusion meropenem----1件: 299 💬
1053Continuous infusion piperacillin tazobactam----1件: 299 💬
1054Continuous infusion ticarcillin-clavulanate----1件: 299 💬
1055Continuous intrajejunal infusion OF levodopa-carbidopa----1件: 6 💬
1056Continuous oxygen----1件: 90 💬
1057Continuous release dopamine agonists----1件: 6 💬
1058Continuous subcutaneous lisuride infusion----1件: 6 💬
1059Contrast enhanced ultrasound----1件: 96 💬
1060Contrast enhanced voiding urosonography with urodynamic testing----1件: 118 💬
1061Contrast media, magnetic resonance----2件: 94, 96 💬
1062Contrast sensitivity measurement----1件: 19 💬
1063Contrast-enhanced ultrasound----1件: 41 💬
1064Control diet----2件: 96, 97 💬
1065Control GEL----1件: 36 💬
1066Control group 0.9% isotonic saline----1件: 299 💬
1067Control group typically developing----1件: 113 💬
1068Control group: mesalazine enema treatment----1件: 97 💬
1069Control multivitamin----1件: 299 💬
1070Control surgery----1件: 6 💬
1071Control wound treatment----1件: 36 💬
1072Controlled-release levodopa / carbidopa----1件: 6 💬
1073Convection enhanced delivery/AAV2-gdnf----1件: 6 💬
1074Conventional----1件: 63 💬
1075Conventional balance exercise----1件: 6 💬
1076Conventional balance training----1件: 13 💬
1077Conventional dmard combination----1件: 46 💬
1078Conventional dmards----1件: 46 💬
1079Conventional drugs----1件: 97 💬
1080Conventional IBD medical treatment----1件: 97 💬
1081Conventional medication----1件: 6 💬
1082Conventional pharmacotherapy----1件: 49 💬
1083Conventional physiotherapy----1件: 6 💬
1084Conventional surgery----1件: 34 💬
1085Conventional synthetic antirheumatic drugs----1件: 46 💬
1086Conventional synthetic dmard----1件: 46 💬
1087Conventional therapy----5件: 6, 49, 67, 97, 222 💬
1088Conventional therapy users FOR THE last 5 years----1件: 271 💬
1089Conventional treatment----2件: 96, 97 💬
1090Conventional white-light colonoscopy----1件: 97 💬
1091Coolonic biopsies----2件: 96, 97 💬
1092Coozar----1件: 167 💬
1093COP-1/copolymer-11件: Glatiramer1件: Glatiramer acetate 💬 20件: MHC1,
MHC1,
MHC1,
MHC1,
MHC1,
MHC1,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2 💬
32件: Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬1件: 13 💬
1094Copanlisib1件: Copanlisib1件: Copanlisib 💬 2件: PIK3CA_B_D,
PIK3CA_B_D 💬
103件: AGE-RAGE signaling pathway in diabetic complications, AMPK signaling pathway, Acute myeloid leukemia, Aldosterone-regulated sodium reabsorption, Alzheimer disease, Amoebiasis, Apoptosis, Autophagy - animal, Axon guidance, B cell receptor signaling pathway, Bacterial invasion of epithelial cells, Breast cancer, C-type lectin receptor signaling pathway, Carbohydrate digestion and absorption, Cellular senescence, Central carbon metabolism in cancer, Chagas disease, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Choline metabolism in cancer, Cholinergic synapse, Chronic myeloid leukemia, Colorectal cancer, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Endometrial cancer, Epstein-Barr virus infection, ErbB signaling pathway, Estrogen signaling pathway, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Fluid shear stress and atherosclerosis, Focal adhesion, FoxO signaling pathway, Gastric cancer, Glioma, GnRH secretion, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatitis B, Hepatitis C, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Hormone signaling, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory mediator regulation of TRP channels, Influenza A, Inositol phosphate metabolism, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leukocyte transendothelial migration, Lipid and atherosclerosis, Longevity regulating pathway, Longevity regulating pathway - multiple species, Measles, Melanoma, MicroRNAs in cancer, Natural killer cell mediated cytotoxicity, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Non-alcoholic fatty liver disease, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Phosphatidylinositol signaling system, Phospholipase D signaling pathway, Platelet activation, Prion disease, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Regulation of lipolysis in adipocytes, Relaxin signaling pathway, Renal cell carcinoma, Salmonella infection, Shigellosis, Signaling pathways regulating pluripotency of stem cells, Small cell lung cancer, Sphingolipid signaling pathway, Spinocerebellar ataxia, T cell receptor signaling pathway, TNF signaling pathway, Thyroid hormone signaling pathway, Toll-like receptor signaling pathway, Type II diabetes mellitus, VEGF signaling pathway, Viral carcinogenesis, Yersinia infection, cAMP signaling pathway, mTOR signaling pathway 💬1件: 121 💬
1095Copaxone1件: Glatiramer1件: Glatiramer acetate 💬 20件: MHC1,
MHC1,
MHC1,
MHC1,
MHC1,
MHC1,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2 💬
32件: Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬1件: 13 💬
1096Copaxone - 20 MG/ML soluzione iniettabile 28 siringhe preriempite1件: Glatiramer1件: Glatiramer acetate 💬 20件: MHC1,
MHC1,
MHC1,
MHC1,
MHC1,
MHC1,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2 💬
32件: Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬1件: 13 💬
1097Copaxone - 20 MG/ML soluzione iniettabile IN siringhe preriempite 30 siringhe1件: Glatiramer1件: Glatiramer acetate 💬 20件: MHC1,
MHC1,
MHC1,
MHC1,
MHC1,
MHC1,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2 💬
32件: Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬1件: 13 💬
1098Copaxone - 40 MG/ML soluzione iniettabile IN1件: Glatiramer1件: Glatiramer acetate 💬 20件: MHC1,
MHC1,
MHC1,
MHC1,
MHC1,
MHC1,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2 💬
32件: Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬1件: 13 💬
1099Copaxone - 40 MG/ML soluzione iniettabile IN siringa preriempita 12 siringhe preriempite DA 1 ML CON AGO1件: Glatiramer1件: Glatiramer acetate 💬 20件: MHC1,
MHC1,
MHC1,
MHC1,
MHC1,
MHC1,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2 💬
32件: Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬1件: 13 💬
1100Copaxone 20 MG----1件: 13 💬
1101Copaxone 20 MG/ML1件: Glatiramer1件: Glatiramer acetate 💬 20件: MHC1,
MHC1,
MHC1,
MHC1,
MHC1,
MHC1,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2 💬
32件: Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬1件: 13 💬
1102Copaxone 20 MG/ML solucióN inyectable EN jeringa precargada1件: Glatiramer1件: Glatiramer acetate 💬 20件: MHC1,
MHC1,
MHC1,
MHC1,
MHC1,
MHC1,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2 💬
32件: Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬1件: 13 💬
1103Copaxone 20 MG/ML solucióN para inyeccióN EN jeringa precargada1件: Glatiramer1件: Glatiramer acetate 💬 20件: MHC1,
MHC1,
MHC1,
MHC1,
MHC1,
MHC1,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2 💬
32件: Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬1件: 13 💬
1104Copaxone 20 MG/ML solution FOR injection, PRE-filled syringe1件: Glatiramer1件: Glatiramer acetate 💬 20件: MHC1,
MHC1,
MHC1,
MHC1,
MHC1,
MHC1,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2 💬
32件: Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬1件: 13 💬
1105Copaxone 20 MG/ML, solution FOR injection, PRE-filled syringes1件: Glatiramer1件: Glatiramer acetate 💬 20件: MHC1,
MHC1,
MHC1,
MHC1,
MHC1,
MHC1,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2 💬
32件: Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬1件: 13 💬
1106Copaxone 20MG/ML solution FOR injection, PRE-filled syringe1件: Glatiramer1件: Glatiramer acetate 💬 20件: MHC1,
MHC1,
MHC1,
MHC1,
MHC1,
MHC1,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2 💬
32件: Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬1件: 13 💬
1107Copaxone 40 MG/ML1件: Glatiramer1件: Glatiramer acetate 💬 20件: MHC1,
MHC1,
MHC1,
MHC1,
MHC1,
MHC1,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2 💬
32件: Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬1件: 13 💬
1108Copaxone 40 MG/ML solution FOR injection, PRE-filled syringe1件: Glatiramer1件: Glatiramer acetate 💬 20件: MHC1,
MHC1,
MHC1,
MHC1,
MHC1,
MHC1,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2 💬
32件: Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬1件: 13 💬
1109Copaxone*SC 28SIR 20MG/ML1件: Glatiramer1件: Glatiramer acetate 💬 20件: MHC1,
MHC1,
MHC1,
MHC1,
MHC1,
MHC1,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2 💬
32件: Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬1件: 13 💬
1110Copaxone-teva----1件: 13 💬
1111Copegus1件: Ribavirin1件: Ribavirin 💬 --1件: 2 💬
1112Copolymer 1----1件: 13 💬
1113Copper1件: Copper---2件: 169, 171 💬
1114Copper (64CU) chloride1件: Copper---1件: 171 💬
1115Copper histidinate1件: Copper---1件: 169 💬
1116Copper histidine2件: Copper,
Histidine
1件: Histidine 💬 --2件: 169, 170 💬
1117COQ101件: Ubidecarenone1件: Ubidecarenone 💬 --4件: 5, 6, 8, 96 💬
1118Coqun----1件: 90 💬
1119COR-003----1件: 75 💬
1120Cord blood----1件: 60 💬
1121Cord blood infusion----1件: 60 💬
1122Cord blood sampling----1件: 227 💬
1123Cord blood transplant----1件: 60 💬
1124Cord blood units----1件: 60 💬
1125Cord sampling----1件: 227 💬
1126Core stability----1件: 13 💬
1127Core stabilization exercises----1件: 6 💬
1128Cormeto - 250 MG capsule molli 50 capsule IN flacone hdpe----1件: 75 💬
1129Corn OIL capsules1件: Corn---1件: 46 💬
1130Corn starch1件: Starch, corn1件: Corn starch 💬 --2件: 49, 97 💬
1131Corn/SOY OIL1件: Corn---1件: 240 💬
1132Cornstarch1件: Starch, corn1件: Corn starch 💬 --1件: 257 💬
1133Cornstarch control1件: Starch, corn1件: Corn starch 💬 --1件: 90 💬
1134CORT113176----1件: 2 💬
1135CORT1251341件: Relacorilant1件: Relacorilant 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 75 💬
1136Cortancyl1件: Prednisone acetate1件: Prednisone acetate 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 41 💬
1137Cortancyl 20 MG1件: Prednisone acetate1件: Prednisone acetate 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬2件: 35, 162 💬
1138Cortancyl ® 1 MG1件: Prednisone acetate1件: Prednisone acetate 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 41 💬
1139Cortancyl ® 20 MG1件: Prednisone acetate1件: Prednisone acetate 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 41 💬
1140Cortancyl ® 5 MG1件: Prednisone acetate1件: Prednisone acetate 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 41 💬
1141Cortecosteroid----1件: 96 💬
1142Cortef----2件: 81, 83 💬
1143Cortef 10MG1件: Hydrocortisone1件: Hydrocortisone 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 81 💬
1144Cortef 5 MG----1件: 83 💬
1145Cortef 5MG1件: Hydrocortisone1件: Hydrocortisone 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 81 💬
1146Corticoids+ tocilizumab 8MG/KG/4 weeks----1件: 41 💬
1147Corticosteroid----7件: 13, 66, 84, 96, 97, 113, 222 💬
1148Corticosteroid and azathioprine----4件: 42, 43, 44, 45 💬
1149Corticosteroid injection----1件: 46 💬
1150Corticosteroid or nsaid----1件: 46 💬
1151Corticosteroide----1件: 113 💬
1152Corticosteroids----12件: 41, 46, 49, 63, 64, 97, 107, 113, 164, 220, 296, 300 💬
1153Corticosteroids & tancart19/20----1件: 13 💬
1154Corticosteroids and immunosuppressants----1件: 55 💬
1155Corticosteroids combined with immunoglobulin and romiplostim----1件: 63 💬
1156Corticosteroids FOR systemic USE----1件: 41 💬
1157Corticosteroids only----1件: 97 💬
1158Corticosteroids'therapy----1件: 35 💬
1159Corticotherapy----1件: 66 💬
1160Corticotrophin 80 units1件: Corticotropin2件: Corticotropin ,
Corticotropin, repository 💬
1件: MC2R 💬 6件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 46 💬
1161Corticotropin1件: Corticotropin2件: Corticotropin ,
Corticotropin, repository 💬
1件: MC2R 💬 6件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬2件: 78, 81 💬
1162Corticotropin-releasing hormone2件: Corticorelin,
Corticotropin
3件: Corticotropin ,
Corticorelin ,
Corticotropin, repository 💬
3件: CRHR1,
CRHR2,
MC2R 💬
7件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Hormone signaling, Long-term depression, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬2件: 75, 205 💬
1163Cortimentmmx 9 MG----1件: 97 💬
1164Cortisol1件: Hydrocortisone1件: Hydrocortisone 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 81 💬
1165Cortisol level1件: Hydrocortisone1件: Hydrocortisone 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 98 💬
1166Cortison----1件: 81 💬
1167Cortisone acetate3件: Cortisone,
Cortisone acetate,
Hydrocortisone
3件: Hydrocortisone ,
Cortisone acetate ,
Cortisone 💬
1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 81 💬
1168Cosentyx1件: Secukinumab1件: Secukinumab 💬 1件: IL17A 💬 6件: Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬4件: 41, 107, 269, 271 💬
1169Cosentyx - 150 MG - soluzione iniettabile IN siringa preriempita -USO sottocutaneo - siringa (vetro) 1 ML (150MG/ML)- 2 siringhe preriempite1件: Secukinumab1件: Secukinumab 💬 1件: IL17A 💬 6件: Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬1件: 107 💬
1170Cosentyx 300 MG solution FOR injection IN PRE-filled syringe1件: Secukinumab1件: Secukinumab 💬 1件: IL17A 💬 6件: Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬1件: 41 💬
1171Cosentyx 300MG solution FOR injection IN PRE-filled syringe1件: Secukinumab1件: Secukinumab 💬 1件: IL17A 💬 6件: Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬1件: 41 💬
1172Cosintropina acetato----1件: 113 💬
1173Cosmofer----2件: 96, 97 💬
1174Cosmofer 50MG/ML solution FOR infusion or injection----2件: 96, 97 💬
1175Costicosteroids----1件: 26 💬
1176Cosyntropin1件: Tetracosactide2件: Cosyntropin ,
Tetracosactide acetate 💬
1件: MC2R 💬 6件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 113 💬
1177Cosyntropin acetate1件: Tetracosactide2件: Cosyntropin ,
Tetracosactide acetate 💬
1件: MC2R 💬 6件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 113 💬
1178Cosyntropin injectable suspension 1 MG/ML + vigabatrin2件: Tetracosactide,
Vigabatrin
3件: Cosyntropin ,
Vigabatrin ,
Tetracosactide acetate 💬
2件: ABAT,
MC2R 💬
12件: Alanine, aspartate and glutamate metabolism, Aldosterone synthesis and secretion, Butanoate metabolism, Cortisol synthesis and secretion, Cushing syndrome, GABAergic synapse, Hormone signaling, Neuroactive ligand-receptor interaction, Propanoate metabolism, Valine, leucine and isoleucine degradation, beta-Alanine metabolism, cAMP signaling pathway 💬1件: 145 💬
1179Cosyntropin injectable suspension, 1 MG/ML1件: Tetracosactide2件: Cosyntropin ,
Tetracosactide acetate 💬
1件: MC2R 💬 6件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 145 💬
1180Cosyntropin stimulation test1件: Tetracosactide2件: Cosyntropin ,
Tetracosactide acetate 💬
1件: MC2R 💬 6件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 83 💬
1181Cotoretigene toliparvovec1件: Cotoretigene toliparvovec---1件: 90 💬
1182Cotrimoxazole----2件: 85, 97 💬
1183Cotton gauze with petrolatum1件: Cotton---2件: 35, 162 💬
1184Cough monitor----1件: 85 💬
1185Coversin1件: Nomacopan1件: Nomacopan 💬 1件: C5 💬 11件: Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬2件: 62, 109 💬
1186Coversyl1件: Perindopril3件: Perindopril erbumine ,
Perindopril ,
Perindopril arginine 💬
1件: ACE 💬 6件: Chagas disease, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system 💬1件: 167 💬
1187Coversyl plus----1件: 19 💬
1188Covid-19 vaccination----1件: 13 💬
1189Covid-19 vaccine----5件: 13, 46, 49, 51, 97 💬
1190Covid-19 vaccine astrazeneca1件: AstraZeneca COVID-19 Vaccine---2件: 46, 51 💬
1191Covid-19 vaccine janssen suspension FOR injection----1件: 299 💬
1192Covid-19 vaccine moderna----4件: 46, 51, 65, 272 💬
1193Covid-19 vaccine moderna dispersion FOR injection1件: Moderna COVID-19 Vaccine1件: Elasomeran 💬 --1件: 299 💬
1194Covid-19 vaccines AT A 3-month interval----2件: 46, 97 💬
1195Covid-19 vaccines AT A 6-month interval----2件: 46, 97 💬
1196Covid19 vaccine----1件: 13 💬
1197Cozaar1件: Losartan2件: Losartan potassium ,
Losartan 💬
1件: AGTR1 💬 17件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hormone signaling, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 167 💬
1198Cozaar 501件: Losartan2件: Losartan potassium ,
Losartan 💬
1件: AGTR1 💬 17件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hormone signaling, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 167 💬
1199Cozaar 50 MG comprimidos recubierto CON pelicula1件: Losartan2件: Losartan potassium ,
Losartan 💬
1件: AGTR1 💬 17件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hormone signaling, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 179 💬
1200Cozaar inicio 12,5 MG comprimidos recubiertos CON pelicula1件: Losartan2件: Losartan potassium ,
Losartan 💬
1件: AGTR1 💬 17件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hormone signaling, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 167 💬
1201CP 690,550----1件: 46 💬
1202CP 690550 MR----1件: 46 💬
1203CP- 690 550----1件: 97 💬
1204CP-101----1件: 97 💬
1205CP-195,543----1件: 46 💬
1206CP-461----1件: 96 💬
1207CP-690, 550 - 10----1件: 46 💬
1208CP-690,500 5 MG----1件: 97 💬
1209CP-690,55-10----1件: 46 💬
1210CP-690,550----4件: 46, 96, 97, 107 💬
1211CP-690,550 + methotrexate1件: Methotrexate2件: Methotrexate ,
Methotrexate sodium 💬
2件: DHFR,
DHFR 💬
3件: Folate biosynthesis, Folate transport and metabolism, One carbon pool by folate 💬1件: 46 💬
1212CP-690,550 10 MG----1件: 97 💬
1213CP-690,550 – 10----1件: 46 💬
1214CP-690,550-10----5件: 46, 96, 97, 107, 271 💬
1215CP-690-550----1件: 46 💬
1216CP-690-550-10----1件: 107 💬
1217CP690,550----2件: 46, 97 💬
1218Cpap group: postoperative cpap support, NON-cpap group: oxygen 3 liters PER minute (L/MIN) either VIA mask FOR those WHO were extubated or through A T-piece FOR those with A trash----1件: 330 💬
1219CPK850----1件: 90 💬
1220CPL409116----1件: 46 💬
1221CPL500036----1件: 6 💬
1222CPL500036 - high dose----1件: 6 💬
1223CPL500036 - LOW dose----1件: 6 💬
1224CPP----1件: 76 💬
1225CPSI-2364----1件: 96 💬
1226CPX----1件: 299 💬
1227CR 1----1件: 46 💬
1228CR 2----1件: 46 💬
1229CR 3----1件: 46 💬
1230CR002 liquid API1件: CR002---1件: 299 💬
1231CR0686----1件: 46 💬
1232CR13C----1件: 113 💬
1233CR60861件: CR6086---1件: 46 💬
1234CR6086Z----1件: 46 💬
1235CR845 1.0 MG----1件: 93 💬
1236Cranberry1件: Cranberry---1件: 13 💬
1237CRC3357, ZK-355322, leukoton----1件: 299 💬
1238CRD-TMH-001----1件: 113 💬
1239CRD007----1件: 113 💬
1240Creapure----1件: 50 💬
1241Creatine1件: Creatine---10件: 1, 2, 6, 8, 13, 46, 49, 50, 201, 337 💬
1242Creatine chemical exchange saturation transfer (crcest) imaging sequence1件: Creatine---1件: 21 💬
1243Creatine monohydrate1件: Creatine---5件: 2, 8, 97, 113, 156 💬
1244Creatine-13C1件: Creatine---1件: 113 💬
1245Creatinine1件: Creatinine1件: Creatinine 💬 --6件: 2, 46, 60, 66, 70, 222 💬
1246Crefmirlimab1件: Crefmirlimab---1件: 51 💬
1247Creon----2件: 298, 299 💬
1248Creon 10.000, HåRDE enterokapsler----1件: 299 💬
1249Creon 10000----2件: 298, 299 💬
1250Creon 10000 capsules----1件: 299 💬
1251Creon 25.000, HåRDE enterokapsler----1件: 299 💬
1252Creon 25000----2件: 298, 299 💬
1253Creon 40.000, HåRDE enterokapsler----1件: 299 💬
1254Creon IR----1件: 299 💬
1255Creon N----1件: 299 💬
1256Creon N 25000----1件: 299 💬
1257Creon® 25,000----1件: 299 💬
1258Crestor1件: Rosuvastatin2件: Rosuvastatin calcium ,
Rosuvastatin 💬
1件: HMGCR 💬 3件: AMPK signaling pathway, Bile secretion, Terpenoid backbone biosynthesis 💬3件: 49, 79, 299 💬
1259Crestor FILM-coated tablet1件: Rosuvastatin2件: Rosuvastatin calcium ,
Rosuvastatin 💬
1件: HMGCR 💬 3件: AMPK signaling pathway, Bile secretion, Terpenoid backbone biosynthesis 💬1件: 79 💬
1260Crestor tablets (calcium rosuvastatin) FILM-coated tablets1件: Rosuvastatin2件: Rosuvastatin calcium ,
Rosuvastatin 💬
1件: HMGCR 💬 3件: AMPK signaling pathway, Bile secretion, Terpenoid backbone biosynthesis 💬1件: 79 💬
1261Crexont ER----1件: 6 💬
1262CRG003 injection----1件: 256 💬
1263CRH----1件: 310 💬
1264CRH administration----2件: 72, 78 💬
1265Crinecerfont1件: Crinecerfont1件: Crinecerfont 💬 1件: CRHR1 💬 5件: Cushing syndrome, Hormone signaling, Long-term depression, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 81 💬
1266Crizotinib1件: Crizotinib1件: Crizotinib 💬 1件: ALK 💬 3件: Non-small cell lung cancer, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways in cancer 💬2件: 2, 34 💬
1267CRN00808----1件: 77 💬
1268CRN00808 IS AN oral NON-peptide small molecule somatostatin receptor 2 (SST2) agonist1件: Somatostatin1件: Somatostatin 💬 5件: SSTR1,
SSTR2,
SSTR3,
SSTR4,
SSTR5 💬
5件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 77 💬
1269CRN00808 è UN agonista DEL recettore 2 della somatostatina (SST2), orale, NON peptidico A piccole dimensioni molecolari----1件: 77 💬
1270CRN00808.HCL----1件: 77 💬
1271CRN04894----1件: 81 💬
1272Crocin and apigenin1件: Crocin---1件: 6 💬
1273Crohn'S disease----3件: 56, 96, 97 💬
1274Crohn'S disease exclusion diet----1件: 96 💬
1275Crohns disease exclusion diet + PEN----1件: 96 💬
1276Cromoglicato disodico----1件: 85 💬
1277Cromoglycate1件: Cromoglicic acid1件: Cromoglicic acid 💬 --1件: 85 💬
1278Cromolyn1件: Cromoglicic acid1件: Cromoglicic acid 💬 --2件: 2, 85 💬
1279Cromolyn sodium1件: Cromoglicic acid1件: Cromoglicic acid 💬 --1件: 85 💬
1280Crono five ambulatory pump----1件: 86 💬
1281Crovalimab1件: Crovalimab1件: Crovalimab 💬 1件: C5 💬 11件: Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬2件: 62, 109 💬
1282Crown----1件: 96 💬
1283CRQ----1件: 46 💬
1284CRX-102----1件: 46 💬
1285CRX-1391件: CRx-139---1件: 46 💬
1286CRX-150----1件: 46 💬
1287Cryopreserved autologous CD34+ cells transduced with A lentiviral vector containing human sgsh gene----1件: 19 💬
1288Cryopreserved autologous CD34+ cells transduced with pcclchim-P47----1件: 65 💬
1289Cryopreserved EFS-ADA LV transduced patient CD34+ cells----1件: 65 💬
1290Cryopreserved G2scid lentiviral vector transduced patient CD34+ cells----1件: 65 💬
1291Cryopreserved myelin-derived peptide-loaded tolerogenic dendritic cells----1件: 13 💬
1292Cryostor CS10----1件: 53 💬
1293Cryosupernatant plasma----1件: 64 💬
1294Crystalline calcium carbonate----1件: 235 💬
1295Crystalline calcium supplements----1件: 235 💬
1296Crystalline cholesterol OIL-based suspension----1件: 310 💬
1297Crysvita (burosumab-twza) treatment1件: Burosumab1件: Burosumab 💬 1件: FGF23 💬 11件: Breast cancer, Calcium signaling pathway, Gastric cancer, MAPK signaling pathway, Melanoma, PI3K-Akt signaling pathway, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton 💬1件: 238 💬
1298CS (corticosteroids) only----1件: 97 💬
1299CS-0777 tablets----1件: 13 💬
1300CS0159----2件: 93, 94 💬
1301CS1----1件: 86 💬
1302CS1 administration----1件: 86 💬
1303CS10br05----1件: 17 💬
1304CSA----5件: 19, 49, 60, 63, 222 💬
1305CSA+ATG+herombopag----1件: 60 💬
1306CSA+herombopag----1件: 60 💬
1307Csdmards----1件: 46 💬
1308CSF sampling----1件: 13 💬
1309CSL312----2件: 65, 85 💬
1310CSL312 garadacimab1件: Garadacimab1件: Garadacimab 💬 1件: F12 💬 1件: Complement and coagulation cascades 💬2件: 65, 85 💬
1311CSL787----1件: 299 💬
1312CSL830----1件: 65 💬
1313CSS----1件: 107 💬
1314CST-103----1件: 6 💬
1315CST-107----1件: 6 💬
1316CST-139----1件: 6 💬
1317CSTI-500----1件: 193 💬
1318CT scan----2件: 65, 75 💬
1319CT- P10----1件: 46 💬
1320CT-G20----1件: 58 💬
1321CT-P10----1件: 46 💬
1322CT-P13----4件: 46, 96, 97, 271 💬
1323CT-P13 SC AUTO-injector----1件: 46 💬
1324CT-P17----1件: 46 💬
1325CT-P17 SC----1件: 46 💬
1326CT-P47----1件: 46 💬
1327CT-P53----1件: 13 💬
1328CT1----1件: 6 💬
1329CT103A cells1件: CT103A---3件: 11, 13, 16 💬
1330CTH120----1件: 206 💬
1331CTI-16011件: CTI-1601---1件: 18 💬
1332CTLA4IG----4件: 46, 49, 96, 271 💬
1333CTX-4430----1件: 299 💬
1334CTX112----1件: 51 💬
1335CU(II)atsm----2件: 2, 6 💬
1336CU-64 dotatate----1件: 84 💬
1337CU104----1件: 97 💬
1338Cudetaxestat1件: Cudetaxestat---1件: 85 💬
1339Cufence1件: Triethylenetetramine2件: Trientine hydrochloride ,
Trientine tetrahydrochloride 💬
--2件: 58, 171 💬
1340CUG252----1件: 49 💬
1341Cultivated oral mucosal epithelial sheet transplantation----2件: 38, 162 💬
1342Culture OF lymphoblastoid line from blood sample----1件: 102 💬
1343Cultured allogeneic fibroblasts----1件: 36 💬
1344Cultured thymus tissue----1件: 65 💬
1345Cultured thymus tissue implantation and parental parathyroid transplantation----1件: 65 💬
1346Cultured thymus tissue implantation with parathyroid transplantation----1件: 65 💬
1347Cumulative corticosteroid exposure----1件: 49 💬
1348Cupping----1件: 70 💬
1349Cuprior1件: Triethylenetetramine2件: Trientine hydrochloride ,
Trientine tetrahydrochloride 💬
--1件: 171 💬
1350Cuprior 150 MG1件: Triethylenetetramine2件: Trientine hydrochloride ,
Trientine tetrahydrochloride 💬
--1件: 171 💬
1351Cuprior 150 MG FILM-coated tablets1件: Triethylenetetramine2件: Trientine hydrochloride ,
Trientine tetrahydrochloride 💬
--1件: 171 💬
1352Cuprior 150MG FILM-coated tablets1件: Triethylenetetramine2件: Trientine hydrochloride ,
Trientine tetrahydrochloride 💬
--1件: 171 💬
1353CURA-100----1件: 46 💬
1354Curcuma longa extract CPL formaat 00 23,2 X 8,5 MM 723 MG1件: Turmeric---1件: 299 💬
1355Curcuma longa rhizoma1件: Turmeric---1件: 96 💬
1356Curcumin1件: Curcumin---10件: 13, 34, 46, 67, 74, 94, 96, 97, 139, 299 💬
1357Curcumin supplementation1件: Curcumin---1件: 97 💬
1358Curie artificial intelligence (AI) cough monitor----1件: 299 💬
1359Curosurf----1件: 211 💬
1360Current treatment----1件: 46 💬
1361Current treatment OF AL-CM----1件: 28 💬
1362Currently available therapy IN THE community----1件: 51 💬
1363Cushing'S syndrome confirmation----1件: 75 💬
1364Custom device----1件: 6 💬
1365Cutaneous biopsy----1件: 162 💬
1366Cutaneous iontophoresis OF treprostinil----1件: 51 💬
1367Cutaquig----1件: 65 💬
1368CUV1647----1件: 254 💬
1369Cuvitru1件: Human immunoglobulin G1件: Globulin, immune 💬 --1件: 65 💬
1370Cuvitru 200 MG/ML solution FOR subcutaneous injection1件: Human immunoglobulin G1件: Globulin, immune 💬 --1件: 65 💬
1371CV-MG011件: CV-MG01---1件: 11 💬
1372CVD00118-E----1件: 6 💬
1373CVL-751----1件: 6 💬
1374CVN424----1件: 6 💬
1375CVN424 150 MG----1件: 6 💬
1376CVN424 75 MG----1件: 6 💬
1377CVT-301----1件: 6 💬
1378CVT-301 35MG----1件: 6 💬
1379CVT-301 50MG----1件: 6 💬
1380CVT-301 high dose----1件: 6 💬
1381CVT-301 LOW dose----1件: 6 💬
1382CVT-301, LIP----1件: 6 💬
1383CVXL-0107----1件: 6 💬
1384CX-016492----1件: 245 💬
1385CX-017950----1件: 245 💬
1386CX-4945 oral formulation----1件: 331 💬
1387CX-8998----1件: 6 💬
1388CX401----1件: 96 💬
1389CX5011件: CX501---1件: 36 💬
1390CX5161件: CX516---1件: 206 💬
1391CX601----1件: 96 💬
1392CXA-101件: CXA-10---2件: 86, 222 💬
1393CY-ATG----1件: 60 💬
1394CYA----1件: 50 💬
1395CYB704----1件: 13 💬
1396Cyberknife----1件: 6 💬
1397CYC----1件: 40 💬
1398CYC202----1件: 299 💬
1399Cyclin D1 gene (CCDN1) /immunoglobulin heavy chain (IGH) fluorescence IN situ hybridization (fish) assay----1件: 28 💬
1400Cycling intervention----1件: 6 💬
1401Cyclo ((diaminoethyl-carbamate)hypro-PHG-(D) TRP-LY DI-aspartate----1件: 75 💬
1402Cyclo ((diaminoethyl-carbamate)hypro-PHG-(D) TRP-LY pamoate----1件: 77 💬
1403Cyclo ((diaminoethyl-carbamate)hypro-PHG-(D)TRP-LY DI-aspartate----1件: 75 💬
1404Cyclo((diaminoethyl-carbamate)hypro-PHG-(D)TRP-LY pamoate----1件: 77 💬
1405Cyclo((diaminoethyl-carbamate)hypro-PHG-(D)TRP-LYS pamoate----1件: 77 💬
1406Cyclo((diaminoethyl-carbamate)hypro-PHG-(D)TRP-LYS-TYR(BZL)-PHE) DI-aspartate----1件: 75 💬
1407Cyclo((diaminoethyl-carbamate)hypro-PHG-(D)TRP-LYS-TYR(BZL)-PHE) pamoate----1件: 77 💬
1408Cyclophosfamide----1件: 13 💬
1409Cyclophosphamid1件: Cyclophosphamide2件: Cyclophosphamide ,
Cyclophosphamide 💬
--2件: 66, 220 💬
1410Cyclophosphamide1件: Cyclophosphamide2件: Cyclophosphamide ,
Cyclophosphamide 💬
--44件: 11, 13, 14, 16, 19, 20, 26, 28, 35, 36, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 56, 60, 62, 65, 66, 84, 93, 96, 162, 164, 172, 205, 221, 222, 224, 265, 274, 283, 284, 285, 288, 326, 331 💬
1411Cyclophosphamide + pred1件: Cyclophosphamide2件: Cyclophosphamide ,
Cyclophosphamide 💬
--1件: 283 💬
1412Cyclophosphamide 100 MG/KG1件: Cyclophosphamide2件: Cyclophosphamide ,
Cyclophosphamide 💬
--2件: 19, 222 💬
1413Cyclophosphamide 100MG1件: Cyclophosphamide2件: Cyclophosphamide ,
Cyclophosphamide 💬
--1件: 60 💬
1414Cyclophosphamide 1200 MG/KG1件: Cyclophosphamide2件: Cyclophosphamide ,
Cyclophosphamide 💬
--2件: 19, 222 💬
1415Cyclophosphamide 150MG1件: Cyclophosphamide2件: Cyclophosphamide ,
Cyclophosphamide 💬
--1件: 60 💬
1416Cyclophosphamide 50MG1件: Cyclophosphamide2件: Cyclophosphamide ,
Cyclophosphamide 💬
--1件: 60 💬
1417Cyclophosphamide 50MG oral tablet1件: Cyclophosphamide2件: Cyclophosphamide ,
Cyclophosphamide 💬
--1件: 162 💬
1418Cyclophosphamide added TO standard immunosuppressive therapy with herombopag1件: Cyclophosphamide2件: Cyclophosphamide ,
Cyclophosphamide 💬
--1件: 60 💬
1419Cyclophosphamide and ATG1件: Cyclophosphamide2件: Cyclophosphamide ,
Cyclophosphamide 💬
--1件: 13 💬
1420Cyclophosphamide and fludarabine1件: Cyclophosphamide2件: Cyclophosphamide ,
Cyclophosphamide 💬
--3件: 11, 13, 16 💬
1421Cyclophosphamide and steroids1件: Cyclophosphamide2件: Cyclophosphamide ,
Cyclophosphamide 💬
--1件: 222 💬
1422Cyclophosphamide dose level 11件: Cyclophosphamide2件: Cyclophosphamide ,
Cyclophosphamide 💬
--2件: 65, 284 💬
1423Cyclophosphamide dose level 21件: Cyclophosphamide2件: Cyclophosphamide ,
Cyclophosphamide 💬
--2件: 65, 284 💬
1424Cyclophosphamide dose level 31件: Cyclophosphamide2件: Cyclophosphamide ,
Cyclophosphamide 💬
--2件: 65, 284 💬
1425Cyclophosphamide dose level 41件: Cyclophosphamide2件: Cyclophosphamide ,
Cyclophosphamide 💬
--2件: 65, 284 💬
1426Cyclophosphamide followed BY methotrexate (azathioprine) + glucocorticoids or methotrexate (azathioprine) + glucocorticoids1件: Cyclophosphamide2件: Cyclophosphamide ,
Cyclophosphamide 💬
--1件: 44 💬
1427Cyclophosphamide injection 1G1件: Cyclophosphamide2件: Cyclophosphamide ,
Cyclophosphamide 💬
--3件: 50, 51, 52 💬
1428Cyclophosphamide LD1件: Cyclophosphamide2件: Cyclophosphamide ,
Cyclophosphamide 💬
--1件: 49 💬
1429Cyclophosphamide monohydrate1件: Cyclophosphamide2件: Cyclophosphamide ,
Cyclophosphamide 💬
--4件: 13, 60, 96, 256 💬
1430Cyclophosphamide post transplant1件: Cyclophosphamide2件: Cyclophosphamide ,
Cyclophosphamide 💬
--1件: 65 💬
1431Cyclophosphamide, azathioprine,prednisone,methylprednisolone2件: Cyclophosphamide,
Prednisone
3件: Cyclophosphamide ,
Prednisone ,
Cyclophosphamide 💬
1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬3件: 42, 43, 45 💬
1432Cyclophosphamide, bortezomib, and dexamethasone (cybord) regimen1件: Cyclophosphamide2件: Cyclophosphamide ,
Cyclophosphamide 💬
--1件: 28 💬
1433Cyclophosphamide, fludarabine1件: Cyclophosphamide2件: Cyclophosphamide ,
Cyclophosphamide 💬
--1件: 285 💬
1434Cyclophosphamide, fludarabine, rabbit ATG1件: Cyclophosphamide2件: Cyclophosphamide ,
Cyclophosphamide 💬
--1件: 60 💬
1435Cyclophosphamide, fludarabine, thymoglobulin1件: Cyclophosphamide2件: Cyclophosphamide ,
Cyclophosphamide 💬
--1件: 60 💬
1436Cyclophosphamide,campath IH and TBI1件: Cyclophosphamide2件: Cyclophosphamide ,
Cyclophosphamide 💬
--1件: 60 💬
1437Cyclophosphamide,cyclosporine A1件: Cyclophosphamide2件: Cyclophosphamide ,
Cyclophosphamide 💬
--1件: 60 💬
1438Cyclophosphamide-prednisone-azathioprine1件: Cyclophosphamide2件: Cyclophosphamide ,
Cyclophosphamide 💬
--1件: 49 💬
1439Cyclophosphamide/ATG1件: Cyclophosphamide2件: Cyclophosphamide ,
Cyclophosphamide 💬
--1件: 13 💬
1440Cyclophosphamide/azathioprine1件: Cyclophosphamide2件: Cyclophosphamide ,
Cyclophosphamide 💬
--1件: 44 💬
1441Cyclophosphamide/glatiramer acetate1件: Cyclophosphamide2件: Cyclophosphamide ,
Cyclophosphamide 💬
--1件: 13 💬
1442Cyclophosphamide/rituximab1件: Cyclophosphamide2件: Cyclophosphamide ,
Cyclophosphamide 💬
--1件: 13 💬
1443Cyclophosphamidum 500 MG1件: Cyclophosphamide2件: Cyclophosphamide ,
Cyclophosphamide 💬
--1件: 44 💬
1444Cycloserine1件: Cycloserine1件: Cycloserine 💬 --1件: 2 💬
1445Cyclosphamine----1件: 85 💬
1446Cyclosporin1件: Cyclosporine1件: Cyclosporine 💬 5件: PPP3C,
PPP3C,
PPP3C,
PPP3R,
PPP3R 💬
33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬9件: 50, 54, 60, 63, 97, 107, 222, 274, 326 💬
1447Cyclosporin A1件: Cyclosporine1件: Cyclosporine 💬 5件: PPP3C,
PPP3C,
PPP3C,
PPP3R,
PPP3R 💬
33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬11件: 46, 49, 53, 54, 56, 60, 62, 93, 95, 113, 164 💬
1448Cyclosporin capsules1件: Cyclosporine1件: Cyclosporine 💬 5件: PPP3C,
PPP3C,
PPP3C,
PPP3R,
PPP3R 💬
33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬1件: 222 💬
1449Cyclosporin, LOW dose steroid1件: Cyclosporine1件: Cyclosporine 💬 5件: PPP3C,
PPP3C,
PPP3C,
PPP3R,
PPP3R 💬
33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬1件: 222 💬
1450Cyclosporine1件: Cyclosporine1件: Cyclosporine 💬 5件: PPP3C,
PPP3C,
PPP3C,
PPP3R,
PPP3R 💬
33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬28件: 11, 28, 40, 41, 42, 45, 46, 49, 50, 53, 56, 60, 61, 62, 63, 64, 65, 97, 107, 162, 164, 222, 226, 228, 283, 284, 285, 302 💬
1451Cyclosporine + BCX73532件: Berotralstat,
Cyclosporine
3件: Cyclosporine ,
Berotralstat ,
Berotralstat hydrochloride 💬
6件: KLKB1,
PPP3C,
PPP3C,
PPP3C,
PPP3R,
PPP3R 💬
34件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Complement and coagulation cascades, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬1件: 65 💬
1452Cyclosporine 0.09% ophthalmic solution1件: Cyclosporine1件: Cyclosporine 💬 5件: PPP3C,
PPP3C,
PPP3C,
PPP3R,
PPP3R 💬
33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬1件: 53 💬
1453Cyclosporine A1件: Cyclosporine1件: Cyclosporine 💬 5件: PPP3C,
PPP3C,
PPP3C,
PPP3R,
PPP3R 💬
33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬11件: 19, 20, 36, 49, 50, 58, 60, 107, 228, 234, 283 💬
1454Cyclosporine combine with mycophenolate mofetil1件: Cyclosporine1件: Cyclosporine 💬 5件: PPP3C,
PPP3C,
PPP3C,
PPP3R,
PPP3R 💬
33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬1件: 283 💬
1455Cyclosporine inhalation solution1件: Cyclosporine1件: Cyclosporine 💬 5件: PPP3C,
PPP3C,
PPP3C,
PPP3R,
PPP3R 💬
33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬1件: 228 💬
1456Cyclosporine oral product1件: Cyclosporine1件: Cyclosporine 💬 5件: PPP3C,
PPP3C,
PPP3C,
PPP3R,
PPP3R 💬
33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬2件: 60, 97 💬
1457Cyclosporine pill1件: Cyclosporine1件: Cyclosporine 💬 5件: PPP3C,
PPP3C,
PPP3C,
PPP3R,
PPP3R 💬
33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬1件: 56 💬
1458Cyclosporine VS infliximab1件: Cyclosporine1件: Cyclosporine 💬 5件: PPP3C,
PPP3C,
PPP3C,
PPP3R,
PPP3R 💬
33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬1件: 97 💬
1459Cyclosporine-A1件: Cyclosporine1件: Cyclosporine 💬 5件: PPP3C,
PPP3C,
PPP3C,
PPP3R,
PPP3R 💬
33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬1件: 95 💬
1460Cyclosporins----4件: 53, 60, 65, 222 💬
1461Cycol----1件: 97 💬
1462Cyklokapron1件: Tranexamic acid1件: Tranexamic acid 💬 1件: PLG 💬 4件: Complement and coagulation cascades, Influenza A, Neuroactive ligand-receptor interaction, Staphylococcus aureus infection 💬1件: 65 💬
1463Cyklokapron tablets1件: Tranexamic acid1件: Tranexamic acid 💬 1件: PLG 💬 4件: Complement and coagulation cascades, Influenza A, Neuroactive ligand-receptor interaction, Staphylococcus aureus infection 💬1件: 65 💬
1464Cyklosporin A----1件: 54 💬
1465Cyltezo1件: Adalimumab1件: Adalimumab 💬 1件: TNF 💬 66件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 96 💬
1466Cymbalta1件: Duloxetine2件: Duloxetine hydrochloride ,
Duloxetine 💬
2件: SLC6A2,
SLC6A4 💬
3件: Neuroactive ligand signaling, Serotonergic synapse, Synaptic vesicle cycle 💬3件: 6, 13, 49 💬
1467CYP substrates----1件: 98 💬
1468CYR-064----1件: 6 💬
1469CYS----1件: 96 💬
1470Cystadane anhydrous----1件: 19 💬
1471Cystadrops1件: Cysteamine3件: Cysteamine ,
Cysteamine hydrochloride ,
Cysteamine bitartrate 💬
--1件: 19 💬
1472Cystadrops 0.55% EYE drops, solution1件: Cysteamine3件: Cysteamine ,
Cysteamine hydrochloride ,
Cysteamine bitartrate 💬
--1件: 19 💬
1473Cystagon1件: Cysteamine3件: Cysteamine ,
Cysteamine hydrochloride ,
Cysteamine bitartrate 💬
--3件: 8, 19, 299 💬
1474Cystagon (cysteamine bitartrate) immediate-release capsules1件: Cysteamine3件: Cysteamine ,
Cysteamine hydrochloride ,
Cysteamine bitartrate 💬
--1件: 299 💬
1475Cystagon 150MG1件: Cysteamine3件: Cysteamine ,
Cysteamine hydrochloride ,
Cysteamine bitartrate 💬
--1件: 19 💬
1476Cystagon 50MG1件: Cysteamine3件: Cysteamine ,
Cysteamine hydrochloride ,
Cysteamine bitartrate 💬
--1件: 19 💬
1477Cysteamine1件: Cysteamine3件: Cysteamine ,
Cysteamine hydrochloride ,
Cysteamine bitartrate 💬
--2件: 19, 299 💬
1478Cysteamine (mercaptamine) viscous solution1件: Cysteamine3件: Cysteamine ,
Cysteamine hydrochloride ,
Cysteamine bitartrate 💬
--1件: 19 💬
1479Cysteamine bitartrate1件: Cysteamine3件: Cysteamine ,
Cysteamine hydrochloride ,
Cysteamine bitartrate 💬
--4件: 8, 19, 21, 299 💬
1480Cysteamine bitartrate (INN: mercaptamine bitartrate1件: Cysteamine3件: Cysteamine ,
Cysteamine hydrochloride ,
Cysteamine bitartrate 💬
--1件: 19 💬
1481Cysteamine bitartrate delayed-release capsules1件: Cysteamine3件: Cysteamine ,
Cysteamine hydrochloride ,
Cysteamine bitartrate 💬
--1件: 19 💬
1482Cysteamine hydrochloride1件: Cysteamine3件: Cysteamine ,
Cysteamine hydrochloride ,
Cysteamine bitartrate 💬
--1件: 19 💬
1483Cysteine1件: Cysteine2件: L-Cysteine ,
Cysteine hydrochloride 💬
--2件: 90, 337 💬
1484Cysteine hydrochloride1件: Cysteine2件: L-Cysteine ,
Cysteine hydrochloride 💬
--1件: 254 💬
1485Cystic fibrosis ready TO USE supplemental food----1件: 299 💬
1486Cystic fibrosis transmembrane conductance regulator1件: Cystic fibrosis transmembrane conductance regulator---1件: 299 💬
1487Cystoscopic injection OF botox into THE urinary bladder----1件: 6 💬
1488CYT107----1件: 25 💬
1489Cytarabine1件: Cytarabine2件: Cytarabine ,
Cytarabine hydrochloride 💬
--7件: 11, 13, 14, 25, 34, 49, 60 💬
1490Cytochrome P450 (CYP) substrates----2件: 96, 97 💬
1491Cytogenetic analysis----1件: 285 💬
1492Cytokine essays----1件: 61 💬
1493Cytokine-treated veto cells----1件: 60 💬
1494Cytokines and chemokine profiling----1件: 49 💬
1495Cytolytic CD4+ T cells----1件: 13 💬
1496Cytoreductive regimen followed BY A CD34+E- selected allogeneic stem cell transplant----1件: 62 💬
1497Cytotoxic combination----1件: 56 💬
1498Cytoxan1件: Cyclophosphamide2件: Cyclophosphamide ,
Cyclophosphamide 💬
--2件: 60, 96 💬
1499CZP----1件: 46 💬
1500Cápsulas DE laquinimod 0.6 MG1件: Laquinimod1件: Laquinimod sodium 💬 --1件: 13 💬
1501Células madre mesenquimales----1件: 13 💬
1502Células madre mesenquimales DE tejido adiposo AUTólogo----1件: 2 💬
1503Células madre mesenquimales haploidénticas derivadas DE Médula óSEA----1件: 36 💬
1504Células mesenquimales DE tejido adiposo----1件: 2 💬
1505Células mesenquimales troncales adultas alogénicas DE Médula óSEA NO expandidas----1件: 274 💬
1506Células mesenquimales troncales adultas AUTólogas DE medula óSEA expandidas----1件: 117 💬
1507Células mesenquimales troncales adultas AUTólogas DE Médula óSEA expandidas----1件: 117 💬
1508Células troncales hematopoyéticas AUTólogas adultas extraidas DE Médula óSEA----1件: 2 💬